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Changes in nighttime sleep, daytime napping, and fatigue are common complaints in older 
adults. This study investigated the association between nighttime and daytime sleep, fatigue, and 
daytime physical function in two cohorts of older adults (75-85 years); The Study of 
Osteoporotic Fractures (SOF) and the Health Aging and Body Composition Study (Health ABC). 
In SOF, measured short sleep duration (≤ 6 hours) was associated with slower gait speed 
and long sleep duration (≥7.5 hours) was associated with longer time to complete 5 chair stands. 
More wake after sleep onset was associated with slower gait speed, longer time to complete 5 
chair stands, lower grip strength and higher odds of Instrumental Activities of Daily Living 
(IADL) impairment. Women with higher daytime sleep took longer to complete 5 chair stands 
and had higher odds of IADL impairment. These findings supported the hypothesis that older 
women with disturbed sleep would have poorer function.  
In Health ABC, there was a wide range of fatigue symptoms. Compared to self-reported 
sleep durations of 7 hrs/night, >8 hrs/night was associated with 7% higher fatigue. Awakening 
during the night or wakening too early in the morning were each associated with 6% higher 
fatigue. These results remained after multivariate adjustment independent of comorbidity. The 
association between disturbed nighttime sleep and reported fatigue symptoms suggests that better 
and more effective behavioral management of sleep may help reduce fatigue in older adults. 
In the Health ABC ancillary sleep study, 75.7% of the participant’s recorded at least one 
nap/week in their sleep-wake diary. Individuals with more fragmented nighttime sleep, self-
reported diabetes, pain, or respiratory symptoms had higher odds of recording a nap. In the group 
that napped neither sleep duration nor fragmentation the night before the nap was associated with 
nap duration the next day. Identification of causes and methods to reduce fragmented sleep may 
help lessen daytime napping in older adults. 
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The public health importance of these findings is that sleep duration and quality are 
important factors in the daytime function of older adults, and may be important targets for 
intervention to improve quality of life. 
 
  v
TABLE OF CONTENTS 
ACKNOWLEDGEMENTS ........................................................................................................ X 
DEDICATION.............................................................................................................................XI 
1.0 INTRODUCTION........................................................................................................ 1 
1.1 DISSERTATION OVERVIEW AND OBJECTIVE........................................ 1 
1.2 BACKGROUND AND SIGNIFICANCE.......................................................... 2 
1.2.1 Sleep changes in older adults ....................................................................... 2 
1.2.2 Prevalence and burden of disturbed sleep, napping, and fatigue in 
community-dwelling older adults ............................................................................... 3 
1.2.3 Assessment of sleep, napping, and fatigue in the community ................... 4 
1.2.4 Association of disturbed nighttime sleep and daytime performance in 
older adults ................................................................................................................... 6 
1.2.5 Association of disturbed nighttime sleep and fatigue in community-
dwelling older adults .................................................................................................... 7 
1.2.6 Association of disturbed nighttime sleep and napping in community-
dwelling older adults .................................................................................................... 8 
1.2.7 Limitations of the existing literature........................................................... 9 
1.3 REFERENCES .................................................................................................. 10 
2.0 ARTICLE ONE: ACTIGRAPHIC MEASURES OF SLEEP ARE ASSOCIATED 
WITH POORER DAYTIME FUNCTIONING IN OLDER WOMEN................................. 18 
2.1 ABSTRACT........................................................................................................ 19 
2.2 INTRODUCTION ............................................................................................. 20 
2.3 METHODS......................................................................................................... 20 
2.3.1 Participants.................................................................................................. 20 
2.3.2 Sleep evaluation........................................................................................... 21 
  vi
2.3.3 Physical function ......................................................................................... 22 
2.3.4 Potential confounders ................................................................................. 22 
2.3.5 Statistical Analysis ...................................................................................... 23 
2.4 RESULTS ........................................................................................................... 24 
2.5 DISCUSSION..................................................................................................... 25 
2.6 ACKNOWLEDGEMENTS .............................................................................. 28 
2.7 REFERENCES .................................................................................................. 29 
3.0 ARTICLE TWO: SLEEP PROBLEMS AND ASSOCIATED DAYTIME 
FATIGUE IN COMMUNITY DWELLING OLDER INDIVIDUALS................................. 40 
3.1 ABSTRACT........................................................................................................ 41 
3.2 INTRODUCTION ............................................................................................. 42 
3.3 METHODS......................................................................................................... 42 
3.3.1 Study Population......................................................................................... 42 
3.3.2 Procedure..................................................................................................... 43 
3.3.3 Data Analysis............................................................................................... 44 
3.4 RESULTS ........................................................................................................... 45 
3.5 DISCUSSION..................................................................................................... 46 
3.6 ACKNOWLEDGEMENTS .............................................................................. 48 
3.7 REFERENCES .................................................................................................. 49 
4.0 ARTICLE THREE: ASSOCIATION BETWEEN NIGHTTIME SLEEP AND 
NAPPING IN OLDER................................................................................................................ 58 
4.1 ABSTRACT........................................................................................................ 59 
4.2 INTRODUCTION ............................................................................................. 60 
4.3 METHODS......................................................................................................... 60 
4.3.1 Study Population......................................................................................... 60 
4.3.2 Sleep ............................................................................................................. 61 
4.3.3 Demographics and General Health ........................................................... 63 
4.3.4 Outcome....................................................................................................... 63 
4.3.5 Comorbid health conditions....................................................................... 63 
4.3.6 Other potential confounders ...................................................................... 64 
4.3.7 Statistical analyses ...................................................................................... 64 
  vii
4.4 RESULTS ........................................................................................................... 65 
4.5 DISCUSSION..................................................................................................... 67 
4.6 ACKNOWLEDGMENT ................................................................................... 70 
4.7 REFERENCES .................................................................................................. 71 
5.0 GENERAL DISCUSSION ........................................................................................ 81 
5.1 SUMMARY OF FINDINGS............................................................................. 81 
5.2 PUBLIC HEALTH SIGNIFICANCE.............................................................. 87 
5.3 FUTURE RESEARCH...................................................................................... 87 
5.4 CONCLUSION .................................................................................................. 89 
5.5 REFERENCES .................................................................................................. 91 
APPENDIX A SUMMARY OF STUDIES ON SLEEP, NAPPING, AND ACTIGRAPHY99 
APPENDIX B  ANCILLARY STUDY ................................................................................... 113 
BIBLIOGRAPHY..................................................................................................................... 126 
  viii
LIST OF TABLES 
Table 2-1 Comparison of Demographic, Health and Performance Variables in the SOF Cohort at 
the 8th clinic visit (2002 – 2004). .................................................................................................. 34 
Table 2-2 Comparison of demographic, health, actigraphic sleep and performance measurements 
by race in the analysis group of the SOF cohort at the eighth clinic visit (2002-2004). .............. 35 
Table 2-3 Daytime performance measures by quartile of Total Nighttime Sleep, Wake After 
Sleep Onset and Daytime Sleep in the Study of Osteoporotic Fracture participants at the eighth 
clinic visit2. ................................................................................................................................... 37 
Table 2-4 Odds of having an IADL impairment by quartile of Total Nighttime Sleep, Wake 
After Sleep Onset and Daytime Sleep in the Study of Osteoporotic Fracture participants at the 
eighth clinic visit........................................................................................................................... 39 
Table 3-1 Participant characteristics at the Health ABC year 5 (2001-2002) clinic visit ............ 53 
Table 3-2 Correlation of the fatigue scale components to the total fatigue score and symptoms of 
disturbed nighttime sleep (Spearman’s rho rs ) in Health ABC year 5 (n=2264) ......................... 55 
Table 3-3 Factors associated with fatigue in multivariable models adjusted for age, race and 
gender and fully adjusted .............................................................................................................. 56 
Table 4-1 Characteristics of Health Aging and Body Composition sleep study participants by 
napping status (N=236)................................................................................................................. 74 
Table 4-2 Odds of taking a daytime nap in the Health Aging and Body Composition Sleep Study 
(n = 235)1 ...................................................................................................................................... 76 
Table 4-3 Regression models showing the temporal association of measured nighttime sleep 
duration and fragmentation ........................................................................................................... 77 
Table 4-4 Multivariable associates of nap duration in the Health ABC sleep study participants 
who reported naps (n = 159). ........................................................................................................ 78 
  ix
Table 4-5 Multivariable associates of previous night sleep and nap duration on nap night sleep 
duration using mixed model analysis in Health ABC sleep study participants who reported 
daytime nap (n = 159) ................................................................................................................... 79 
Table 4-6 Predictors of average nap duration (hour) in Health ABC sleep study participants who 
reported a daytime nap (n = 178). ................................................................................................. 80 
Table A5-1 Summary of epidemiologic studies evaluating sleep in older adults...................... 100 
Table A.5-2 Summary of epidemiological studies evaluating sleep duration and mortality ..... 105 
Table A.5-3 Summary of studies on napping in the community ............................................... 107 
Table A.5-4 Summary of studies of on napping and actigraphy in older adults........................ 109 
ACKNOWLEDGEMENTS 
I would like to thank everyone who made this accomplishment possible: 
Dr. Anne B. Newman, my advisor and doctoral committee chair, for her unwavering 
patience, guidance, and support. The depth of knowledge she instilled was invaluable to my 
professional growth. Thank you for pushing me past limits I never thought possible. 
The remainder of my doctoral committee: Dr. Robert Boudreau, not only for taking the 
time to help with the analyses, but for filling in the gaps in my biostatistical education. Dr. Jane 
A. Cauley, my original advisor and a major source of my GSR funding, for her invaluable 
feedback throughout my graduate program and research studies. Dr. Martica Hall, for her 
guidance into the realm of sleep research, and Dr. Karen A. Matthews, for her in-depth review 
and critique of my dissertation research. 
I would also like to acknowledge the staff at the Department of Epidemiology, Health 
Studies Research Center, for their help in my independent research project, support and 
friendship throughout my time as a GSR at the facility. In particular, The Health ABC study 
research staff, for their help and assistance in assuring my research was included in their already 
busy clinic visit.  
Special appreciation goes to my family for their continual support, especially my husband 
Tracy Ott without whom this endeavor would not have been possible. 
Last, but not least, the participants in Health ABC and SOF studies for their participation 
in these research projects. 
DEDICATION 
This dissertation is dedicated to the people who mean the most to me in the world. 
 
To Tracy, my best friend and partner for life, for whom this endeavor would not have been 
undertaken or completed. To Amy, my sister and other best friend, for always being there 
especially through those darkest days. To Gayle, my mom, for her support and always believing 
in me. To my grandparents, Helen and Mac Resnick, who are always with me in thought and 
who would have been so happy to see this day. 
 
Finally, to my two sources of unconditional love, Honey Bear and Teddy Bear. 
  
  1
1.0  INTRODUCTION 
1.1 DISSERTATION OVERVIEW AND OBJECTIVE 
Changes in nighttime sleep, daytime napping, and fatigue are common complaints in older 
adults, and are associated with reduced daytime performance and function, medical comorbidity 
and cognitive decline 1. Theses changes may have negative consequences on functioning and 
quality of life 2, 3. Over half of all adults 65 years of age, or older, suffer with disturbed sleep at 
some point in time. About two-thirds of older individuals experience some type of sleep problem 
at least a few nights per week 4, 5. Existing information on the association of nighttime sleep 
problems with daytime napping, fatigue, and daytime function is primarily based on self-report 
data rather than with objectively measured sleep and/or function. Sleep duration and quality are 
important factors in the daytime function of older adults. Research is needed to determine how 
nighttime sleep patterns are associated with subsequent daytime napping, fatigue, and function in 
individuals as they reach the eighth decade of life. These associations may be important target 
areas for intervention to improve quality of life. 
The objective of this dissertation was to examine the relationship between nighttime and 
daytime sleep behaviors, daytime fatigue, and daytime function in older adults. Nighttime and 
daytime sleep was evaluated subjectively by self-report and objectively quantified with wrist 
actigraphy. The three dissertation papers addressed the following: 
1. Are total night time sleep duration and sleep fragmentation, measured with actigraphy, 
associated with daytime function in community dwelling older women? 
2. Is daytime fatigue, measured with a standardized fatigue questionnaire, related to self-
reported hours of sleep, disturbed nighttime sleep, or napping in community dwelling 
older adults?  
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3. Are nighttime sleep duration or fragmentation, measured with actigraphy, associated with 
measured daytime sleep (napping) and nap duration in community dwelling older adults? 
1.2 BACKGROUND AND SIGNIFICANCE 
1.2.1 Sleep changes in older adults 
Sleep changes with aging 1, 6, 7. Changes occur in sleep quality, duration, continuity, architecture, 
and circadian cycles 8. Older individuals spend more time in stage 1 sleep, stage 2 sleep is either 
longer or shows no change, and there is less stage 3, stage 4 sleep (deep sleep), and REM sleep 6, 
9, 10. As stage 1 sleep is considered to indicate the degree of sleep disruption the increase in time 
denotes a greater percentage of sleep fragmentation.  
In general, older individuals spend more time in bed, obtain over an hour less sleep 
nightly, have more night time awakenings, reduced sleep efficiency, and take more naps 11, 12. 
Sleep disturbances commonly associated with older individuals include difficulty initiating or 
maintaining sleep, nocturnal wakening, waking up too early in the morning, waking not rested, 
as well as irregular sleep times, short total sleep duration, and daytime napping 1, 7, 13-15.  
Compared with younger individuals older individuals sleep more (average of 7.1 
(weekdays) to 7.2 (weekends) hours and 6.9 to 7.1 hours, respectively), and their sleep problems 
are often associated with existing comorbid medical and psychiatric diseases, physical, and 
psycho-social factors 1, 4, 16, 17. Further, older people are sleepy during the day, suggesting that the 
ability to sleep at night is shortened with age 7, 18, 19. Upwards of 15% of older people have 
sleepiness so severe during the day that it interferes with their daily activities, while an additional 
11-12% experience it a few days a month 4.  
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1.2.2 Prevalence and burden of disturbed sleep, napping, and fatigue in community-
dwelling older adults 
Sleep disturbances in older adults are associated with significant morbidity and mortality 3, 20-24, 
can result in daytime impairment 1, 25, and are increasingly recognized as part of a geriatric 
syndrome 23. Sleep disturbances can have a strong, negative effect on the quality of life 2. The 
association of short (≤6 hours) and long sleep duration (>8 hours) with up to 15% higher 
mortality has been reported in multiple studies 11, 23, 26-29 (Table A.1.1).  
Prevalence rates of poor sleep in older adults range from 13–57% dependent on the 
specific sleep complaint being evaluated 1, 3, 21, 24, 30. Based on the types of direct and indirect 
costs included in the estimate, costs of insomnia across the life-span have been estimated to 
range from approximately $13.9 billion to over $30 billion dollars (1995 dollars) 31-34 and tens of 
billions annually in 2005 35. Additional associated costs range from $50 billion 36 to as high as 
$100 billion annually when lost productivity, medical expenses, sick leave, property, and 
environmental damages are included 5, 34. A summary of epidemiological studies evaluating sleep 
in older adults is presented in Table A.1.2.  
Napping is common in older individuals 37, 38. Estimates of the proportion of older 
individuals who nap range from 24 – 64% 1, 4, 13, 39-41. The economic burden directly associated 
with napping in older adults has not been established. However, daytime napping can result in 
impaired cognition, impaired performance, more accidents, and psycho-social problems that can 
compromise the individuals quality of life 1, 33, 42, 43. 
The prevalence and economic burden associated with fatigue in community- dwelling 
older adults is not known; however the prevalence of fatigue in older adults living in assisted 
living facilities was found to be as high as 98% with over 50% of the residents expressing mild 
to severe fatigue levels 44. The prevalence of fatigue in other populations, ranges from 6–45 % in 
primary care patients 45-47, to as high as 67% in older women a year after a myocardial infarction 
48, to over 75% in individuals receiving chemotherapy.  
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1.2.3 Assessment of sleep, napping, and fatigue in the community 
Assessment of sleep can be performed in the laboratory or home. Methods include 
polysomnography (PSG), wrist actigraphy, sleep logs and diaries, and questionnaires. PSG is 
considered the gold standard for measuring sleep 49. PSG allows for measurement of at least 3 
types of data (EEG, EOG, and EMG) which jointly determine sleep architecture and if a person 
is asleep or awake. It also allows for simultaneous recording of multiple physiologic parameters 
during sleep 7, 50, 51. However, PSG has several drawbacks. PSG needs to be manually scored and 
interpreted by trained specialists, it is costly to obtain and score, and even with home monitoring 
it is difficult to administer in large population studies. Additionally, PSG is cumbersome, semi-
invasive, and can disturb an individuals’ sleep which often leads to a “first night” effect as the 
individual adjusts to the equipment. Finally, PSG provides data for only the time of recording 7, 
49, 51. 
Wrist actigraphy has been used to evaluate sleep/wake patterns for over 20 years. It is 
based on the premise that during sleep there is little movement, while during wake there is more 
movement. Actigraphy has been demonstrated to be an effective means of measuring sleep in 
older adults 49, 50. Wrist actigraphs can record data continuously over 24 hour periods, can be 
used as an adjunct to routine evaluation of sleep disorders, and is useful in special populations 
like demented older adults. Further, it is suitable for population studies due to its ease of 
administration and use and lower cost than PSG. Actigraphy data are analyzed with computer 
algorithms designed to determine levels of activity/inactivity, rhythm parameters, and sleep/wake 
variables 50. Results from reliability studies, comparing actigraphy and EEG to distinguish wake 
from sleep, have ranged from 0.89–0.98 in healthy normal sleepers to 0.78 to 0.88 in individuals 
presenting to sleep disorder clinics 49. Studies generally agree that although actigraphy is not as 
accurate as PSG for specific sleep measurements only obtainable by PSG, it is more reliable than 
sleep logs, and can record continuously for 24-hrs a day for long periods of time 49, 50, 52-54. 
Actigraphy can also provide information obtained in no other way, such as in demented 
individuals, or in situations where PSG or sleep diaries are not suitable 50 . A summary of studies 
using actigraphy to measure sleep are presented in table A.1.3. 
Sleep diaries provide subjective estimates of sleep parameters 55. Sleep diaries vary in 
complexity, from a simple chart to a complex diary, dependent on the particular research project. 
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Sleep diaries have a high percentage of agreement with polysomnography (kappa=0.87), with a 
sensitivity and specificity of 92.3% and 95.6%, respectively 56. When compared to actigraphy, 
the reliability for measurement of night time sleep duration was r=0.69 (p<0.001) 57. While sleep 
diaries and wrist actigraphy provide comparable estimates of total sleep duration and sleep 
efficiency, the wrist actigraph records more nocturnal awakenings then recalled on sleep diaries 
57. Sleep diaries can provide fairly reliable information, however they require considerable 
commitment on the part of the individual to complete 58.  
In population studies interview-administered questionnaires are frequently used to assess 
disorders of initiating and maintaining sleep 59. Sleep questions may include: “How many hours 
of sleep do you usually get at night?”; “During a usual week, how many times do you nap?”; “At 
what time do you usually go to bed?”; “At what time do you usually awake?”; “How often do 
you experience difficulty falling asleep?”; “How often do you wake up during the night and have 
difficulty getting back to sleep (frequent awakenings)?”; “How often do you wake up too early in 
the morning and are unable to get back to sleep (early morning awakenings)?”; “How often do 
you take sleeping pills or other medication to help you sleep?”; and “Do you ever have 
sleepiness during the day that is so severe it required a nap or interferes with your activities?”  
Test-retest reliability of sleep questionnaires has been shown to be fairly high. In a 6 and 
12 month follow-up of cardiac surgery patients the reliability was found to be 0.58, with internal 
consistency coefficients of 0.63 for a 3 item scale and 0.79 for a 4 item scale 59. Test-retest 
correlations in a younger cohort (mean age 29.3 years) for total sleep time in 2 interviews 1 
month apart was 0.87 and 0.93 respectively (p<0.01) 60. In that same study, self-reported point 
estimates of bedtime and wake time were strongly correlated with the median time reported in 
the sleep diaries (r=0.93, p<0.001) 60. 
In summary, PSG is the “gold standard” for sleep measurement. Sleep diaries and 
actigraphy however have been shown, in multiple studies, to provide reliable data in situations 
where PSG would be unavailable, not feasible or impractical. Situations where the evaluations of 
sleep-wake patterns over multiple nights are of interest, such as large population studies, are 
particularly suited to the use of sleep diaries and/or actigraphy. Actigraphy is more reliable then 
sleep diaries that rely on an individuals recall 50, 53, it is a cost-effective method to evaluate sleep 
patterns 61, and less cumbersome to the individual.  
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Assessment of daytime naps usually has been done by interview-administered 
questionnaires, or with self-reported sleep logs 37, 62. However, sleep diaries may underestimate 
actual napping frequency as naps are often not recorded by the individual 12, 37. Wrist actigraphy 
has been used in conjunction with sleep logs 12, 38, 62, 63, however this can be biased towards 
higher numbers of naps if periods of wakefulness without movement such as watching TV are 
scored as napping 12, 62, 64. 
Fatigue is more difficult to measure than nighttime sleep or napping. Fatigue is multi-
dimensional 46, 65-67 and there are over 30 measurement scales reported in the literature 68. These 
scales have been developed, and tested, in various populations in order to quantify the 
multidimensionality of this syndrome 44, 66, 69-74. The more complex fatigue scales typically 
include questions to assess areas of behavior, affect, cognition and mood, and global distress. 
The majority of scales were developed and tested in cancer patients, or other populations with 
chronic illness. A study has been performed in older adults living in assisted living facilities 
using the modified Piper fatigue scale 44. 
As discussed later, the term fatigue is often used interchangeably with daytime 
sleepiness, although these are distinct concepts. Most fatigue scales do not evaluate or exclude 
sleepiness. Daytime sleepiness however, can be measured in the clinic setting with scales such as 
the Epworth Sleepiness Scale, or the Stanford Sleepiness Scale that are designed to estimate the 
likelihood of falling asleep in different situations 75 In the laboratory sleepiness is measured with 
the Multiple Sleep Latency Test which is a test of the physiological measure of sleepiness 76.  
1.2.4 Association of disturbed nighttime sleep and daytime performance in older adults 
Correlations between disturbed sleep and morbidity have been consistently observed, however a 
causal relationship between sleep disturbances and decreased physical performance has not been 
established 33. In middle aged adults, chronic insomnia is associated with work days missed, 
impaired work performance, and automobile accidents 35.  In older adults, sleep complaints are 
associated with a higher prevalence of physical disabilities 13. In one large study of older adults 
those with self-reported symptoms of insomnia had 17% higher odds of an ADL limitation, 
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while those who woke feeling not rested were 23% more likely to have a limitation with 
ambulation 13.  
1.2.5 Association of disturbed nighttime sleep and fatigue in community-dwelling older 
adults 
The association between disturbed nighttime sleep (short and long sleep durations, difficulty 
initiating and maintaining sleep and waking up during the night) and fatigue has not been 
established. Fatigue is a multi-dimensional, non-specific, syndrome 47, 65, 71, 77-79 described as 
weariness, weakness, and depleted energy. Fatigue is a common complaint in older adults that 
can affect quality of life 44, 80. The association of fatigue and chronic disease has been well 
established. Fatigue is related to depression 78, myocardial infarction 48 and to changes in the 
sleep/wake cycles and quality and quantity of sleep in cancer 65, 66, 71, 73, 81 and rheumatoid 
arthritis patients 65, 82. 
Fatigue is often confused with daytime sleepiness. Although separate constructs 83, 
fatigue and daytime sleepiness may overlap due to the multidimensionality of fatigue and the 
measurement tool used to define fatigue or sleepiness. Both include an aspect of tiredness, and 
are often used interchangeably, even though they are distinct phenomenon 45, 47, 65, 68, 84. 
Tiredness and fatigue have been shown to predict development of disability with basic activities 
of daily living 85. The impact of fatigue on daily living, in older adults, is about twice that of  the 
impact of daytime sleepiness in younger adults 80. Due to its confusion with sleepiness, or other 
complaints, fatigue may be under-recognized and under-treated 47, 68, 86, 87.  
It has been suggested that fatigue is an important health indicator in the elderly 88. It is 
known that older adults who complain of tiredness are at a higher risk of becoming disabled 89, 90. 
Since tiredness is a component of fatigue, and fatigue is thought to be distinct from daytime 
sleepiness, the potential that fatigue is associated with changes in sleep in older adults which 
may subsequently affect physical activity and performance exist. 
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1.2.6 Association of disturbed nighttime sleep and napping in community-dwelling older 
adults 
Daytime napping increases in frequency and duration with aging 8, 30, 37, 39, 91, 92 and does not 
appear to differ significantly by age or gender 39, 40. The association between nighttime sleep and 
napping, and napping and daytime function, in older adults is not clearly defined. A cycle of 
fragmented nighttime sleep, reduced sleep efficiency, fatigue and napping has been reported 93, 
with nap duration a major factor in the association 8. Studies evaluating napping in older adults 
have been performed in the nursing home 94, 95; as small laboratory controlled studies where 
napping is measured with PSG; evaluated by one or two questions in a larger study; or assessed 
with actigraphy as part of larger study (Table A.1.2 and Table A.1.3.).  
A variety of studies that have used PSG, actigraphy, or self-report data have found 
nighttime sleep variables (total sleep time, sleep efficiency, wakening up during the night, 
waking up too early) did not differ between days when the individual napped and days when 
there were no naps. These studies also found no differences between the individuals who took 
more frequent or less frequent naps 37, 55, 64, 96-98. Other studies have found higher frequencies of 
daytime naps to be associated with: shorter total sleep time 99, awakening not feeling rested in 
the morning 92, 100, early morning wakening (6:04 am ±1:06 hr versus 7:02 am ±1:12 hr, p=0.001) 
62, 101, and more sleep complaints. One small laboratory study (n=9) found when total sleep time 
was added to nap time, in the nap group although there was a non-significant difference between 
total day plus night sleep time between the nap participants and the non-nap participants (nap 
group 6.3 (1.0) hrs, non nap group 6.6 (1.1) hrs p>0.25) 41.  
The association of napping on the overall well being, and performance, of older adults is 
not clear 8. Laboratory studies measuring the effects of daytime naps with performance, 
generally have evaluated cognitive and psychomotor performance tasks using tests such as the 
visual detection tasks, logical reasoning task, two-letter visual search task, Stroop congruency 
task, Wilkinson four-choice reaction time test, and the mini-mental status exam. Significant 
improvement in these performances has been shown in some studies 96, 98, 102. However, other 
studies have shown reduced performance 103, reduced physical activity 104, or no improvement 41, 
92. Based on existing studies it is difficult to make a conclusion to whether or not night time sleep 
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is directly associated with daytime napping, as well as if napping benefits daytime functioning in 
the community dwelling older.  
1.2.7 Limitations of the existing literature 
Although sleep disturbances, daytime napping, and fatigue are known to be common in older 
adults they are not to be considered consequences of aging 17, 105. There are few studies of the 
associations between disturbed sleep and daytime function, disturbed sleep and fatigue, and 
disturbed sleep and daytime napping focused specifically on these associations in community-
dwelling older adults. Especially lacking are studies in this population using objective measures 
of sleep and nap behaviors. Although studies have evaluated the effects of sleep disturbances 20, 
daytime sleepiness 23, napping, and fatigue 44 on populations that include older individuals, these 
epidemiologic studies in general did not have sleep or nap parameters as either the primary 
exposure or primary outcome. Other studies on napping and function have been performed in 
small groups of individuals in controlled laboratory settings. Research specifically designed to 
evaluate the complex relationship between sleep, napping, and fatigue is needed to further 
understand the association between them and daytime function in community dwelling older 
adults.
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2.1 ABSTRACT 
Introduction: Poor sleep is associated with impaired daytime performance. Few studies have 
quantified sleep patterns and daytime function with objective measures. We hypothesized that 
older women with disturbed sleep would have poorer daytime function. 
Methods: Nighttime sleep activity was assessed in 2962 women (mean age (SD = 83.3(3.6) 
years; 10.7% were black) who wore wrist actigraphs (average (SD)=4.1(0.8) nights) during the 
2002-2004 examination of the Study of Osteoporotic Fractures. Total nighttime sleep, hours 
awake after sleep onset, and total daytime sleep were assessed along with gait speed, time to 
complete five chair stands, grip strength, and self-reported difficulty with one or more of six 
instrumental activities of daily living (IADL). Associations between quartiles of total nighttime 
sleep, wake after sleep onset, and daytime sleep and daytime function were evaluated using 
linear regression models adjusted for factors associated with sleep and/or function. Relationships 
between sleep and nap patterns and IADL impairments were analyzed using logistic regression. 
Results: Women who slept <6 hours walked 3.5% slower than those who slept 6-6.8 
hours/night; while those who slept ≥7.5 hours took 4.7% longer to complete 5 chair stands than 
those who slept 6.8-7.5 hours/night. As wake after sleep onset rose from <0.7 to ≥1.6 hours gait 
speed was 11.4% slower, it took 7.4% longer to complete 5 chair stands, and odds of IADL 
impairment rose to 1.5(95%CI 1.2, 2.0). Women with 1-1.8 hrs of daytime sleep had higher odds 
of IADL impairment (1.3(95%CI 1.0, 1.6) than women with <0.5 hours of daytime sleep.  
Conclusion: Older women with short and long sleep durations, more wake after sleep onset, and 
longer daytime sleep functioned poorer and were more likely to report IADL impairments. 
Results were not completely explained by poor health status among those with disturbed sleep. 
Treatment of sleep disturbance in older women may prevent some of the functional decline 
attributed to aging. 
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2.2 INTRODUCTION 
Sleep problems are common in older adults with over half of community dwelling adults 
reporting some chronic sleep complaint 106, 107.  Sleep durations of <7 or >8 hours per night, as 
well as complaints of daytime sleepiness, are associated with higher morbidity and mortality 23, 
27, 104, 108, 109. Subjective measures of poor sleep have been associated with poorer health 110-112 
and reduced physical function in older adults 13, 16, 109, 113. In addition, subjective evidence 
suggests that over 15% of older adults reporting ambulatory limitations also report abnormal 
sleep patterns 4. Prior studies have been limited by the lack of objective measures of sleep and 
physical function. 
Maintenance of function is important for maintaining quality of life in older adults. 
Functional evaluation provides critical information on the health status of older adults 114. 
Measures of lower-extremity function 115 and hand grip strength 116  have been shown to be 
related to disability, morbidity and mortality.  
The present analysis uses data from the multi-center Study of Osteoporotic Fractures, to examine 
the relationship of objective measures of sleep and nap patterns and daytime function in a large 
cohort of community-dwelling older women. We hypothesized that older women with short or 
long nighttime sleep duration, more disrupted sleep, and more daytime sleep would have poorer 
daytime function. 
2.3 METHODS 
2.3.1 Participants 
Women were enrolled in The Study of Osteoporotic Fractures (SOF), a longitudinal study of risk 
factors for fracture.  To be eligible to participate, women had to be community-dwelling, at least 
65 years of age, and ambulatory at the initial visit 1986-88. Women who reported a bilateral hip 
replacement were excluded. Women were recruited from population-based listings at four 
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clinical centers in the United States: Baltimore, Maryland; Minneapolis, Minnesota; Portland, 
Oregon; and the Monongahela Valley near Pittsburgh, PA. The initial study cohort consisted of 
9704 Caucasian women recruited between 1986–1988 117 and an additional 662 African 
American women added in 1996-1998 117, 118. After enrollment, follow-up clinic visits were 
conducted approximately every two years. A total of 4,727 women participated in an eighth 
clinic visit (year 16) between January 2002 and April 2004. At this visit 3,127 performed wrist 
actigraphy, of which 165 were excluded from this analysis because they resided in either a 
personal care facility or nursing home. The SOF study was approved by the institutional review 
board at each participating institution, and all participants provided written informed consent. 
2.3.2 Sleep evaluation 
Sleep and nap patterns were assessed objectively using wrist actigraphy (Sleep-Watch-O®, 
Ambulatory Monitoring, Inc., Ardsley, NY). Actigraphs were worn on the non-dominant wrist 
for a minimum of three 24-hour periods (mean 4.1 ± 0.83 nights, range 1-9 nights) 50. Details of 
the actigraphy collection and scoring have previously been reported 119. Briefly, actigraphy data 
used in this analysis were collected in the proportional integration mode (PIM), also referred to 
as the digital integration mode. Sleep and wake cycles were differentiated using the UCSD sleep-
scoring algorithm 120. The algorithm calculates a moving average taking into account the activity 
levels immediately before and after the current minute to determine if the time point should be 
coded as sleep or wake. Participants also completed a sleep diary for the duration of time they 
wore the actigraph, which was used in the editing of the actigraphy data to determine bed time 
and final up time, and to record naps and periods of watch removal (e.g. for bathing). 
Actigraphy variables computed included total nighttime sleep time calculated as the 
hours scored as sleep between bedtime and final up time. Wake after sleep onset was calculated 
as the average number of hours awake after sleep onset, where sleep onset was scored as the 
completion of 20 continuous minutes of sleep after getting into bed. Total sleep during the day 
(or number of hours of napping) was calculated as the average minutes of inactivity (minimal 
movement detected by the actigraphy) between the final get up time that morning and the 
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subsequent bedtime. Actigraphy data for each participant was averaged over all 24-hour periods 
to reduce night-to-night variability. 
Self reported sleep problems, including physician diagnosis of a sleep disorder, awakening 
during the night to urinate, trouble sleeping due to leg jerks or cramps, breathing difficulties 
while sleeping, or snoring were also collected. 
2.3.3 Physical function 
Physical function was assessed by trained examiners at the eighth clinic visit and included: gait 
speed measured with the 6 meter usual pace test (meters/sec); time to complete 5 chair stands 
(seconds); and the average of right and left grip strength (kg) 121. Physical function was also 
assessed by self-report of difficulty performing any of six instrumental activities of daily living 
(IADL) that included walking 2-3 blocks, climbing or walking down 10 steps, preparing meals, 
heavy housework, and shopping 122, 123. 
2.3.4 Potential confounders 
Information about potential confounders previously identified as associated with sleep in the 
SOF cohort 124 was collected at the eighth clinic visit along with the sleep variables and 
actigraphy data. Information included medical history, anthropomorphic measurements of weight 
(kg) and height (m), and self reported walking for exercise. Depressive symptoms were 
measured with the Geriatric Depression Scale 125. Anxiety was measured using the Goldberg 
Anxiety Scale Score 126. Mental status was measured with the Mini-Mental Status Exam (range 
0-30), with higher scores representing better cognitive function 127, 128. A comorbidity index 
(number of comorbid conditions coded as 0, 1, 2, 3+) was created that consisted of self reported 
history of stroke, diabetes, Parkinson’s disease, Alzheimer’s disease, heart disease, congestive 
heart failure, COPD, and hypertension at the eighth clinic visit. Hand tremors were evaluated by 
the clinic staff during the trails B test. 
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2.3.5 Statistical Analysis 
In descriptive univariate analysis physical performance measures and variables previously 
reported as associated with disturbed sleep in the SOF cohort 124 were compared in participants 
attending the eighth clinic visit who were and were not included in this analysis. Sleep 
parameters, performance outcomes, and potential confounders were also compared between the 
black and white participants who were included in this analysis sample. Characteristics were 
summarized as means and standard deviations for continuous variables and counts and 
percentages for categorical variables. Comparisons were performed using t-tests for normally 
distributed continuous data, Wilcoxon rank sum tests for skewed continuous data, and Pearson’s 
chi-squared test for categorical data. 
Sleep parameters were categorized into quartiles to examine potential non-linear, or U-
shaped, relationships with performance measurements. The U-shaped distribution between total 
nighttime sleep and the physical performance measurements was further evaluated by entering a 
quadratic term for total nighttime sleep in regression models.  Individual sleep variables were 
examined as the independent variable with gait speed, chair stand time, grip strength, and IADL 
impairment as the dependent variables.  IADL impairment (yes/no) was defined as having any 
difficulty with at least one of the six IADL’s. Linear regression models were used to examine the 
relationship between sleep variables and continuous performance outcomes. Logistic regression 
models were used to examine the relationship between sleep variables and the dichotomous 
IADL outcome. All models were adjusted for potential confounders known to affect both 
physical function and sleep 124. These included age, race, BMI (body mass index (kg/m2)), 
depression, anxiety, cognitive function, comorbidities, and walking for exercise. Results for time 
to complete 5 chair stands were additionally adjusted for whether the participant used their arms 
during the chair stand test, and results for grip strength were adjusted for presence of hand 
tremors. Statistically significant differences between each pair of quartiles were assessed using 
the least square means procedure. Data were analyzed using STATA V8.1 (Stata Corporation, 
College Station, TX) and SAS V8 (SAS Institute, Cary, NC ) software.  Two-sided p-values < 
0.05 were considered statistically significant. 
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2.4 RESULTS 
Characteristics of the 2962 participants in the analysis sample compared with the remaining 1765 
participants at the eighth clinic visit (2002 – 2004) are shown in Table 2.1. The mean age of the 
participants with actigraphy was significantly lower than the rest of the participants. Those with 
actigraphy had a higher BMI, better self-reported health status, fewer comorbid health 
conditions, less depression and more self reported sleep problems. More individuals with 
actigraphy walked for exercise and had a faster walk speed. Fewer of these individuals had any 
IADL impairments. They were also able to get up and down from a chair faster and had stronger 
average grip strength. 
Confounding characteristics, sleep measurements, as recorded by actigraphy, and 
performance measurements for the white and black participants are presented in Table 2.2. 
Significant racial differences were found in all sleep categories except self-reported sleep 
problems and daytime sleep duration. Black women had less total nighttime sleep and more 
fragmented sleep as represented by the time spent awake during the sleep period.  Black women 
functioned more poorly on the 6 meter walk test (m/sec) and the time to complete 5 chair stands, 
however their grip strength was stronger. In addition, the black women were younger, had a 
higher BMI, poorer self-reported health, and more comorbidities. All subsequent analyses were 
adjusted for race.  
The multivariate distribution of performance measures across quartiles of total nighttime 
sleep, wake after sleep onset, and daytime sleep are presented in Table 2.3, and the odds for 
IADL impairment are presented in Table 2.4. Women in the lowest and highest quartiles of total 
nighttime sleep performed more poorly on the gait test and took longer to complete 5 chair 
stands. In the fully adjusted model women who averaged <6 hours sleep per night still had 3.5% 
slower gait speed than the women who averaged 6-6.8 hours of sleep, and women who averaged 
≥7.5 hours of sleep per night took 4.7% longer to complete 5 chair stands than those who slept 
6.8-7.5 hours/night. The quadratic term was significant (p<0.001) between total nighttime sleep 
and gait speed, but not between total nighttime sleep and time to complete 5 chair stands. 
Women who spent more time awake during the night (more wake after sleep onset) had 
slower gait speed, took longer to complete 5 chair stands, and had weaker grip strength. These 
findings were slightly attenuated in the fully adjusted model. Women with more wake after sleep 
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onset also had more IADL impairment. After adjustment women in the highest quartile (≥1.6 
hrs) still had 1.54(95%CI 1.20, 2.00) higher odds for an IADL impairment compared to women 
with less than 0.7 hours of wake after sleep onset. Women who slept more during the day walked 
slower, took longer to complete 5 chair stands, and had weaker grip strength. These findings 
however were attenuated by adjustment. Compared to women with daytime sleep <0.5 hrs a day 
those women who slept 1-1.8 hrs or ≥1.8 hrs during the day had higher odds of IADL 
impairment after adjustment (1.28(95%CI 1.01, 1.63) and 1.23(95%CI 0.96, 1.57), respectively).  
2.5 DISCUSSION 
This analysis is one of the first large scale analyses to examine the effect of sleep patterns in 
community dwelling older women on daytime function using objective measurements of sleep 
and physical function. This study showed that actigraphically measured short or long nightly 
sleep duration and more wake after sleep onset (fragmentation) were associated with slower gait 
speed and increased time to complete 5 chair stands. Higher levels of fragmentation, as well as 
more daytime sleep, were also associated with higher odds of IADL impairment. These findings 
persisted even after adjustment for risk factors associated with both sleep and function. 
Detrimental effects of sleep deprivation on alertness and performance  have been shown 
in controlled studies 129, 130, however it has not been demonstrated in a population based setting. 
The use of actigraphy to measure nighttime activity and sleep fragmentation has been 
documented in several studies 131-133. Further, the use of performance assessment has been shown 
to be an important tool as a measurement of functioning in older adults 134. With the use of both 
techniques we have been able to show that the women in SOF with poorer sleep performed more 
poorly on standardized tests.  
We found that black women had shorter total nighttime sleep and more wake after sleep 
onset than white women. Ethnic differences have been reported on how individuals experience 
normal sleep. Studies have found that blacks are less likely to complain of sleep disturbances 
then are whites 135-137. However, in general blacks have been shown to take longer to fall asleep, 
to have more disruptive sleep, and to sleep more during the day 137. The black women in the SOF 
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cohort were recruited an average of 10 years after the white women and therefore tended to be 
significantly younger than the white women. However, similar to previous reports 137 the SOF 
black women had more risk factors for poor sleep such as higher BMI, poorer self-reported 
health status, and more medical comorbidity. 
In this study a U shaped distribution was found for total nighttime sleep and gait speed 
with women at both extremes functioning more poorly when compared to the women who 
averaged 6-7.5 hours of sleep. Adjustment for multiple confounders explained only a portion of 
the relationship between total nighttime sleep and the performance measures.  The association of 
both long and short nightly sleep time with poorer function is in concordance with the patterns 
associated with sleep time and self reports of health problems 4, 138, or mortality 23, 27, 139, 140 
previously reported in the literature. Individuals sleeping 6 to 7 hours per night have been 
reported to have the lowest risk of mortality 11, 27-29, 141, 142. The women with a total nighttime 
sleep between 6 – 7.5 hrs appeared to function better. Potentially, regulating total nighttime sleep 
may play an important role in minimizing functional decline.  
Fragmented sleep occurs chronically in older populations 130 and has been correlated with 
daytime sleepiness 93. Indeed frequent nighttime awakening is a cardinal symptom of sleep 
complaints in the older adult. A major finding of this study was the more fragmented the 
participants’ nighttime sleep, the worse the daytime performance was even after adjustment for 
multiple potential confounders. This was true for all performance measures. Brief disruptions of 
sleep have been shown to be less restorative than consolidated sleep, to result in significantly 
altered sleep stage distribution, the appearance of daytime sleepiness, and decreased performance 
on reaction time and digit symbol substitution tests 93, 143-147. Although frequent awakenings have 
not been shown to be associated with mortality 23, the significant reduction in daytime function 
associated with it warrants attention to the complaint in a clinical setting. 
In this study we found that periods of daytime sleep ≥1 hour when compared to those 
with <0.5 hours, as measured by actigraphy, were also related to poorer daytime performance. 
Studies have shown an association between napping and self reports of daytime sleepiness, self 
reported poorer health, impaired physical function or mood, being overweight, mortality, 
cardiovascular disease, myocardial infarction, and congestive heart failure 23, 104, 138, 148. Reports 
of daytime sleepiness have also been shown to be an independent predictor of mortality and 
cardiovascular disease in older adults 23, 104, 148. We adjusted for the aforementioned variables and 
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the relationship between daytime sleep and performance was only partially explained. In small, 
controlled studies the effects of napping on cognitive and psychomotor performance have been 
contradictory. Some studies have shown significant improvement 96, 102 while another showed 
negligible effects 41. 
The relationship between sleep behavior and physical performance is complex with this 
study suggesting that poor sleep may impact daily function. We found slower gait speed 
associated with both short and long sleep durations, as well as with more wake after sleep onset. 
Walking speed has been shown to be an independent determinant of self-rated health with slower 
walk speed associated with poor self-rated health 149. Physical performance measures of lower 
extremity function, and particularly gait speed, have been shown to predict the onset of 
progressive ADL impairment, mobility, and upper extremity disability in older women 115, 150. In 
the SOF cohort direct measurement of neuromuscular performance including gait speed has been 
strongly related to disability 151. 
Handgrip strength has also been shown to be a strong predictor of cause-specific and total 
mortality in older disabled women 116 and to be associated with reports of more difficulties in the 
physical activities of daily living 152. We found a decrease in handgrip strength as the amount of 
wake after sleep onset increased. Our women had an average grip strength already considered to 
be low 116, 152. Since they are still functional, improvement in their sleep behavior may minimize 
subsequent decline.  
Strengths of this study include the data are from a large sample of community dwelling 
women, both black and white, in a well established and followed cohort. State of the art wrist 
actigraphs were used for sleep measurements. Performance measurements were made by well-
trained clinicians. However, this study also has some limitations. The analysis subset is healthier 
than the overall SOF cohort, and may not be representative of the general cohort of older women. 
This would be expected to bias relationships towards the null. Further, our findings may not be 
generalizable to other populations including non-ambulatory women, younger women, men, or 
institutionalized individuals. Finally, results are cross-sectional and one cannot determine if sleep 
disturbance precedes impairments in performance, or vice versa. 
In summary, disrupted sleep was associated with poorer daytime function in these older 
women. As total nighttime sleep deviated from an approximate average of 7 hours, gait speed 
was slower and it took longer to complete 5 chair stands. As quartile of wake after sleep onset 
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increased gait speed was slower and it took longer to complete 5 chair stands. Finally, as the 
amount of fragmentation or daytime sleep increased odds for IADL impairment were higher. 
These findings were not fully explained by adjustment for demographic or health conditions. 
Longitudinal studies are needed to determine if poor sleep patterns are causally associated with 
functional decline. Potentially, treatment of sleep disorders can prevent part of the functional 
decline attributed to aging. 
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Table 2-1 Comparison of Demographic, Health and Performance Variables in the SOF Cohort at the 8th clinic 
visit (2002 – 2004). 
 Analysis Sample 
n=2962 
Remaining Sample 
n=1765 
p-value 
Age (years) (mean ± SD) 83.3 ± 3.6 84.9 ± 4.3 < 0.001 
Race:   0.01 
   Black (n (%)) 317 (10.7) 149 (8.4)  
   White (n (%)) 2645 (89.3) 1616 (91.6)  
BMI (kg/m2) (mean ± SD) 26.9 ± 4.9 26.0 ± 5.2 0.009 
Self reported health status (n (%))   <0.001 
      Excellent 567 (19.2) 277 (15.9)  
      Good 1673 (56.5) 839 (48.2)  
      Fair 659 (22.3) 490 (28.1)  
      Poor 59  ( 2.0) 137 (7.9)  
Comorbidity1 (n (%))   <0.001 
      None  809 (27.3) 352 (21.7)  
      One 1221 (41.3) 646 (39.9)  
      Two 618 (20.9) 382 (23.5)  
       ≥ Three 310 (10.5) 242 (14.9)  
Sleep Problems2 (mean ± SD) 3.9 ± 1.9 3.5 ± 1.9 <0.001 
Depression (GDS15) (mean ± SD) 3.5 (3.4) 2.4 (2.6) <0.001 
Anxiety (Goldberg Anxiety Score) (mean ± SD) 1.4 ± 2.3 1.3 ±2.2 0.57 
Mini Mental Status Exam (mean ± SD) 27.0 (2.7) 27.8 (2.0) <0.001 
Walks for exercise (n (%)) 1092 (37.3) 504 (31.6) <0.001 
Gait Speed (m/sec) (mean ± SD) 0.8 ± 0.2 0.7 ± 0.3 <0.001 
IADL3 (n (%) with no impairment) 1415 (47.8) 235 (13.3) <0.001 
Chair Stands4 (seconds) (mean± SD) 13.5 ± 4.7 14.1 ± 4.8 <0.001 
Grip Strength5 (kg) (mean ± SD) 16.5 ± 4.0 14.7 ± 4.4 <0.001 
 
 
1 Comorbid conditions at the eighth clinic visit (stroke, diabetes, Parkinson’s disease, Alzheimer’s disease, COPD, 
heart disease, congestive heart failure, and hypertension).  
2 Number of self reported sleep problems (self report of sleep disorder, getting up to go to the bathroom, leg jerks 
while sleeping, breathing difficulty while sleeping, snoring, or sleep apnea). 
3 Instrumental Activities of Daily Living: walking 2-3 blocks, climbing or walking down 10 steps, preparing meals, 
heavy housework, and shopping. 
4 Seconds to complete 5 chair stands. 
5Average of right and left grip strength. 
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Table 2-2 Comparison of demographic, health, actigraphic sleep and performance measurements by race in the analysis group of the SOF cohort at the 
eighth clinic visit (2002-2004). 
 
  White (N=2645)  Black (N=317)  
DEMOGRAPHICS: (n)  (n)  p 
Age (years) (mean±SD) 2645 83.7±3.2 317 79.6±4.5 <.01 
BMI (kg/m2) (mean±SD) 2609 26.5±4.6 313 29.3±5.6 <.01 
HEALTH STATUS:      
Self-reported health status (n (%)) 2642  317  .03 
      Excellent  521 (19.7)  46 (14.5)  
      Good  1496 (56.6)  177 (55.8)  
      Fair  576 (21.8)  84 (26.5)  
      Poor   49 (1.9)  10 (3.2)  
Comorbidity1 (n (%)) 2642  317  <.01 
      None   764 (28.9)  45 (14.2)  
      One  1087 (41.1)  134 (42.3)  
      Two  535 (20.3)  84 (26.5)  
       ≥ Three  256 (9.7)  54 (17.0)  
Depression (GDS15) (mean ± SD) 2639 2.4 (2.6) 317 2.2 (2.3) 0.09 
Anxiety (Goldberg  Anxiety Score) (mean ± SD) 2638 1.3 (2.2) 317 1.5 (2.4) 0.34 
Mini Mental Status Exam (mean ± SD) 2517 27.9 (1.9) 295 27.3 (2.4) <0.001 
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  White (N=2645)  Black (N=317)  
SLEEP (mean ± SD):      
Sleep Problems2  1672 3.9±1.9 208 3.6±1.8 .5 
Total Nocturnal Sleep Time (hrs) 3 2576 6.8±1.3 314 6.3±1.3 <0.01 
Wake After Sleep Onset (hrs) 3 2575 1.2±0.7 314 1.5±0.8 <0.01 
Total Daytime Sleep Time (hrs) 3 2542 1.2±1.0 303 1.1±1.2 0.7 
FUNCTION:      
Walks for exercise (n (%)) 2610 972 (37.2)  316 120 (38.0) .8 
Gait Speed (m/sec)4 (mean ± SD) 2466 0.83±0.2 292 0.77±.2 <0.01 
IADL (n (%) with none)6 2645 1263 (47.7) 317 152 (48.0) 0.9 
Average Grip Strength (kg)7 (mean ± SD) 2453 16.2±3.8 294 18.3±4.4 <0.01 
Chair Stands (seconds)8 (mean ± SD) 1955 13.4±4.7 226 13.7±4.1 0.02 
 
1 Comorbid conditions at the eighth clinic visit (Self report of stroke, diabetes, Parkinson’s disease, Alzheimer’s disease, COPD, heart disease, congestive heart 
failure, and hypertension).  
2 Number of self reported sleep problems (self report of sleep disorder, getting up to go to the bathroom, leg jerks while sleeping, breathing difficulty while 
sleeping, snoring, and sleep apnea). 
3 Measured by actigraphy.  
4 6 meter usual pace 
6 Instrumental Activities of Daily Living:  walking 2-3 blocks, climbing or walking down 10 steps, preparing meals, heavy housework, and shopping.  
7Average of right and left grip strength. 
8 Seconds to complete 5 chair stands.  
 
Table 2.2 cont. 
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Table 2-3  Daytime performance measures by quartile of Total Nighttime Sleep1, Wake After Sleep Onset 1and Daytime Sleep1 in the Study of 
Osteoporotic Fracture participants at the eighth clinic visit2. 
 
 Total Nighttime Sleep (Hours) 
Means(standard error) < 6.0 6.0  - 6.8 6.8  -7.5 ≥7.5 
Gait Speed (m/sec) Unadjusted 0.81(0.01)a 0.85(0.01)a,b 0.86(0.01)a, c 0.83(0.01)b,c 
      Adjusted2 0.83(0.01)a 0.86(0.01)a 0.85(.01) 0.84(0.01) 
Chair Stands (sec) Unadjusted 14.05(0.22)a 13.56(0.21) 13.23(0.21)a,c 13.89(0.21)c 
     Adjusted2,3 13.77(0.21) 13.51(0.19) 13.31(0.20)c 13.93(0.20) c 
Grip Strength (kg) Unadjusted 16.78(0.16) 16.71(0.10) 16.58(0.16) 16.72(0.16) 
    Adjusted2,4 16.66(0.16) 16.76(0.15) 16.72(0.15) 16.72(0.16) 
 Wake After Sleep Onset  (Hours) 
 <0.7 0.7 – 1.1 1.1 – 1.6 ≥1.6 
Gait Speed (m/sec) Unadjusted 0.90(0.01)a 0.85(0.01)a,b 0.84(0.01)a,c 0.76(0.01)a,b,c 
      Adjusted2 0.88(0.01)a 0.84(0.01)a,b 0.85(0.01)a,c 0.78(0.01) a,b,c 
Chair Stands (sec) Unadjusted 13.05(0.20)a 13.43(0.20)b 13.77(0.21)a,c 14.70(0.23)a,b,c 
     Adjusted2,3 13.24(0.19)a 13.58(0.19) b 13.61(0.20)c 14.22(0.23) a,b,c 
Grip Strength (kg)  Unadjusted 16.93(0.16)a 16.63(0.16) 16.69(0.16) 16.25(0.16)a 
    Adjusted2,4 16.91(0.15)a 16.74(0.15) 16.80(0.15) 16.37(0.17) a 
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Table 2.3 cont. Daytime Sleep (Hours) 
 < 0.5 0.5 -1.0 1.0 -1.8 ≥1.8 
Gait Speed (m/sec) Unadjusted 0.88(0.01)a 0.85(0.01)a,b 0.83(0.01)a,b ,c 0.80(0.01) a,b, c 
      Adjusted2 0.85(0.01) 0.85(0.01) 0.84(0.01) 0.84(0.01) 
Chair Stands (sec) Unadjusted 13.33(0.02)a 13.20(0.21)b 13.51(0.21)c 14.68(0.22) a,b, c 
     Adjusted2,3 13.57(0.19) 13.27(0.20)b 13.53(0.20) 14.04(0.28)b 
Grip Strength (kg)  Unadjusted 16.87(0.16)a 16.68(0.16) 16.75(0.16)c 16.29(0.16)a,c 
    Adjusted2,4 16.71(0.16) 16.75(0.16) 16.80(0.16) 16.63(0.16) 
 
1 Measured with wrist actigraphy (Actillume ®). Total nighttime sleep=average hours sleep in bed at night; Wake after sleep onset=average hours of wake after 
sleep onset: Daytime sleep = average hours of sleep, out of bed. 
2 Adjusted for age, race, BMI, depression (GDS15), anxiety (Goldberg Anxiety Score 0-9), cognitive function (MMSE), number of comorbidities (Doctor ever 
told you: stroke, diabetes, Parkinson’s disease, Alzheimer’s disease, chronic obstructive pulmonary disease, heart disease (heart attack or coronary event), 
congestive heart failure, and hypertension), and walking for exercise. 
3 Also adjusted for use of arms. 
4 Also adjusted for hand tremors. 
a,b,c Differences between quartile with same letter are statistically significant p<0.05. 
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Table 2-4 Odds of having an IADL impairment1 by quartile of Total Nighttime Sleep2, Wake After Sleep Onset2 and Daytime Sleep2 in the Study of 
Osteoporotic Fracture participants at the eighth clinic visit. 
 
 Total Nighttime Sleep (Hours) 
 < 6.0 6 .0- 6.8 6.8  -7.5 ≥7.5 
Odds ratio (CI)   Unadjusted 1.14(0.92, 1.40) Referent 0.75(0.61, 0.92) 1.14(0.93, 1.40) 
      Adjusted3 0.95(0.75, 1.21) Referent 0.77(0.61, 0.97) 1.13(0.89, 1.44) 
 Wake After Sleep Onset (Hours) 
 <0.7 0.7 – 1.1 1.1 – 1.6 ≥1.6  
Odds ratio (CI)   Unadjusted Referent 1.20(0.98, 1.50) 1.50(1.21, 1.83) 2.41(1.90, 2.98) 
      Adjusted3 Referent 1.10(0.87, 1.40) 1.26(0.99, 1.60) 1.54(1.20, 2.00) 
 Daytime Sleep (Hours) 
 < 0.5 0.5 -1 1 -1.8 ≥1.8  
Odds ratio (CI)   Unadjusted Referent 1.14(0.91,1.41) 1.74(1.41, 2.15) 2.18(1.76, 2.70) 
      Adjusted3 Referent 0.95(0.75,1.32) 1.28(1.01, 1.63) 1.23(0.96, 1.57) 
 
1 Difficulty with at least 1 of the following 6 Instrumental Activities of Daily Living:  walking 2-3 blocks, climbing or walking down 10 steps, preparing meals, 
heavy housework, and shopping.  
2 Total nighttime sleep = Average hours sleep in bed at night; Wake after sleep onset=Average hours Wake After Sleep Onset; Daytime sleep=average hours 
sleep, out of bed. 
3 Adjusted for age, race, BMI, depression (Geriatric Depression Score), anxiety (Goldberg Anxiety Score), cognitive function (MMSE), number of comorbidities 
(Doctor ever told you: stroke, diabetes, Parkinson’s disease, Alzheimer’s disease, chronic obstructive pulmonary disease, heart disease (heart attack or coronary 
event), congestive heart failure, and hypertension), and walking for exercise. 
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3.1 ABSTRACT 
Introduction: Fatigue contributes to disability and restricted activity in older adults, yet specific 
determinants of fatigue are not well defined. Sleep duration and insomnia complaints may 
represent modifiable risk factors to reduce fatigue. 
Methods: Fatigue was examined with a subscale of the Modified Piper Fatigue Scale (0-50; 
higher score indicating higher fatigue) in 2264 (52% women, 37% black) older adults aged 75-84 
years (mean(SD) 77.5(2.9)) participating in the 2001-2002 visit of the Health Aging and Body 
Composition (Health ABC) study. Associations of fatigue with self-reported hours of sleep/night 
and insomnia complaints of difficulty initiating or maintaining sleep, and use of sleep 
medications were evaluated separately, and then in multivariable models adjusted for age, sex, 
race, body mass index, self-reported health, depression, cardio-pulmonary disease, dyspnea, and 
physical activity. 
Results: The average fatigue score was 17.7(8.4) (scale 0-50). Compared to sleeping 7 hrs/night, 
>8 hrs/night was associated with a 7% higher fatigue score and awakening during the night or 
wakening too early in the morning were each associated with a 6% higher fatigue score. These 
associations remained after multivariate adjustment independent of comorbidity. 
 Conclusion: There was a wide range of fatigue symptoms in these community dwelling older 
adults. The association between disturbed nighttime sleep and reported fatigue symptoms 
suggests that better and more effective behavioral management of sleep may help reduce fatigue 
in older adults. 
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3.2 INTRODUCTION 
Fatigue is a multi-dimensional, non-specific, syndrome 1-8 that has been described as  weariness, 
weakness, tiredness and depleted energy 5, 9. Fatigue is common in older adults, can affect 
quality of life 10, and is often confused with daytime sleepiness. Although separate constructs 11, 
fatigue and daytime sleepiness may overlap due to the multidimensionality of fatigue and the 
measurement tool used to define fatigue or sleepiness. Questionnaires to determine fatigue may 
12, 13, or may not 14, evaluate sleepiness as a component of fatigue. The estimated prevalence of 
fatigue ranges from 6 to 45% depending on the population surveyed and measurement scale used 
5, 15, 16. In older adults tiredness and fatigue predict development of disability in basic activities of 
daily living 17.The impact of fatigue on daily living in older adults is about twice as high as the 
impact of daytime sleepiness on daily living in younger adults 18. 
Insomnia and other sleep disturbances are also common in older adults with prevalence 
rates estimated as high as 50% 19, 20. These also can result in decreased quality of life 19. 
Although sleep complaints and fatigue are thought to be related, this association has not been 
evaluated with consideration of the contribution of comorbidity in community dwelling older 
adults. This study assessed the prevalence of fatigue in community-dwelling older adults and 
hypothesized that fewer hours of sleep and/or difficulty with initiating or maintaining sleep 
would be associated with higher fatigue scores. 
3.3 METHODS 
3.3.1 Study Population  
The Health Aging and Body Composition (Health ABC) study, a prospective cohort study of 
3,075 well functioning black (42%) and white (58%) men (48.4%) and women (51.6%), was 
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designed to investigate changes in body composition, health conditions, social and behavioral 
factors on physical and functional decline. Participants were recruited from a random sample of 
white Medicare beneficiaries, and all community-dwelling black residents, in designated zip-
code areas around Pittsburgh PA and Memphis TN. Eligibility criteria included: age 70–79 years 
during the recruitment period from March 1997-1998, self-report of no difficulty walking one-
quarter of a mile, or walking up 10 steps without resting, having no difficulties performing basic 
activities of daily living, no use of assistive devices or equipment to get around, being free of 
life-threatening illness, no history of active treatment for cancer in the past 3 years, no current 
enrollment in a lifestyle intervention treatment, and no plans for moving out of the area within 3 
years. Participants were re-examined annually. This report concerns 2264 participants examined 
in 2001-2002. All participants gave informed written consent and the consent forms and protocol 
were approved by the Institutional Review Boards at each center. 
3.3.2 Procedure 
At the year 5 clinic visit (2001-2002) interviewer-administered questionnaires included detailed 
questions about sleep, fatigue, medical history, and physical activity. Sleep and napping behavior 
were assessed by the following questions: “How many hours of sleep do you usually get at night 
during a usual week?” and “How many times a week do you nap for 5 minutes or more?” 
Insomnia symptoms were evaluated with a series of questions in which participants were asked 
how often they experienced: 1) trouble falling asleep, 2) waking up during the night and having 
difficulty getting back to sleep, 3) waking up too early in the morning and being unable to get 
back to sleep, 4) taking sleeping pills or other medication to help sleep. Responses were 
categorized as: never, rarely (≤once/month), sometimes (2–4 times/month), often (5–15 
times/month), or almost always (16–30 times/month). 
Fatigue was measured with a subscale identified from factor analysis of the original 25-
item Piper Fatigue Scale originally developed for use in breast cancer patients 12. This scale has 
also been used in a group of older individuals residing in a long-term care facility 10. Participants 
were asked the following questions in reference to the past month: 1) how weak did you feel; 2) 
how sleepy did you feel during the day; 3) how lively did you feel; 4) how tired did you feel; and 
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5) what was your usual energy level. Responses could range from 0-10 with 10 indicating the 
most severe level. A total fatigue score ranging from 0 (no fatigue) to 50 (highest fatigue)  was 
obtained by summing the scores for each item after reversing the scoring for the questions on 
liveliness and energy level as in the Revised Piper Fatigue Scale 12.  
Self-reported health status was assessed with the question “In general how would you say 
your health is?” with response options excellent, very good, fair, poor, or don’t know. Cardio-
pulmonary disease was assessed as self-report of congestive heart failure, coronary heart disease, 
or stroke. Self-reported dyspnea on exertion was classified separately. Physical activity was 
assessed by self report and calculated as the total kilocalories/week engaged in walking and 
climbing stairs 21. Depression was assessed with the 10-item Center for Epidemiologic Studies 
Depression Scale (CESD 10) 22. Anthropometric measurements, including height measured with 
a stadiometer and weight measured with a balance beam scale were also obtained. Body mass 
index (BMI) (kg/m2) was computed and categorized into 3 groups: <25 kg/m2 as normal, 25-29 
kg/m2 as overweight, and ≥30 kg/m2 as obese 23. Demographic characteristics (age, sex, and 
race) were defined by self report. 
3.3.3 Data Analysis 
Descriptive statistics were performed on all variables to evaluate range, frequencies, normality, 
and inconsistencies in the data. Differences between race and gender were tested using chi-
square tests and student’s t-tests. Age, race, BMI, depression, self-reported health status, cardio-
pulmonary disease, physical activity, and performance factors were all considered as possible 
confounders of the association between sleep and fatigue and were treated as covariates 1, 10, 11, 24-
29.  
For analyses purposes, based on initial examination of the data, hours of sleep were 
categorized as 6 or fewer hours, 7, 8, and more than 8 hours. Insomnia symptoms of trouble 
falling asleep, waking up during the night, waking up too early in the morning, and taking 
sleeping medicines were collapsed into 2 categories: “infrequent” comprising never or rarely 
experiencing any symptom; and “frequent” comprising experiencing at least one symptom 
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sometimes, often, or almost always. Approximately 60% of the participants fell into the 
infrequent category for each sleep symptom. 
Potential associations between the individual fatigue scale components and nighttime 
sleep behaviors were examined using Spearman rank order correlation coefficients. The 
association between the total fatigue score and each sleep variable was examined using separate 
linear regression models. Additional factors found significant in univariate analysis were then 
included using progressively more complex multivariable models. Model 1 adjusted for age, 
race, and gender. Model 2 added all sleep variables plus age, race and gender. Model 3 added 
BMI, depressive symptom score, self-reported health status, and cardio-pulmonary factors. 
Model 4 added kilocalories/kg/week expended walking and climbing stairs. To express the 
strength of the associations, percent differences were calculated from the regression coefficients 
with the formula (beta*unit/mean fatigue score) 30. Factors found significantly associated with 
fatigue are reported at p≤0.05. Analyses were performed using SAS version 8.2 (SAS Institute, 
Cary, NC) and STATA version 8 (STATA Corporation, College Station, TX).  
3.4 RESULTS 
Fatigue scores ranged from 0 to 50 with a mean(SD) fatigue score of 17.7(8.4). Men reported 
lower fatigue then women. There was no difference in average fatigue levels between blacks and 
whites. Black women did not differ from white women and black men did not differ significantly 
from white men, in their average fatigue score. Mean hours of self-reported nightly sleep did not 
differ by gender, although a higher percentage of men napped at least 7 times a week compared 
to women. Over 39% of participants reported at least 1 insomnia symptom, with higher 
percentages of women reporting each insomnia symptom relative to men (Table 5). 
Total fatigue, as well as each question on the fatigue scale, was slightly correlated with 
the individual symptoms of disturbed sleep. Removal of the question “over the past month how 
sleepy did you feel during the day” from the fatigue scale did not change the associations 
between fatigue and the individual sleep behaviors (Table 6). In separate linear regression 
models for each nighttime sleep variable, adjusted for age, race, and gender, both short (≤6 
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hours) and long sleep duration (>8 hours) were associated with higher levels of fatigue when 
compared to self-reported sleep duration of 7 hours. Higher levels of fatigue were also associated 
with trouble falling asleep, waking up during the night, waking up too early, and use of sleep 
medications (Table 7). Results were similar when all sleep variables were considered together in 
the same model.  
In the fully adjusted multivariable regression model, self-reported long sleep duration (>8 
hours), waking up during the night, and waking up too early remained associated with higher 
fatigue scores. In general, these associations were slightly attenuated after adjustment. Trouble 
falling asleep at night, while associated with higher fatigue in the unadjusted models, was not 
associated with fatigue in the fully adjusted model. Also associated with higher average fatigue 
scores were: poorer self-reported health status, high depressive symptoms, prevalent cardio-
pulmonary disease and dyspnea. These associations were also attenuated in the fully adjusted 
model. Individuals who engaged in walking or climbing stairs equivalent to >5.3 kcal/kg/week 
had lower fatigue scores than individuals with ≤0.03 kcal/kg/week of activity. The final 
multivariable model explained 36% of the overall variance in the fatigue score. Finally, factors 
associated with high levels of fatigue (fatigue score >30) were examined to determine if any 
factors were specifically related to these higher levels. Results were consistent with the results of 
the linear model.  
3.5 DISCUSSION 
This study is one of the first to examine the independent contribution of sleep with fatigue in a 
large cohort of predominately high functioning community dwelling older adults. In this cohort 
there was a wide range of fatigue symptoms. Individuals who reported sleeping >8 hours a night 
had higher total fatigue scores then those sleeping ≤8 hours. Persons who reported waking up 
during the night or waking up too early in the morning, also had higher total fatigue scores. 
These associations remained even after adjustment for multiple confounders. In those individuals 
who reported sleeping ≤6 hours per night, or who had trouble falling asleep, the fatigue appeared 
to be attenuated by other health reasons. The association of symptoms of poor sleep and fatigue 
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may be important in explaining aspects of fatigue beyond those due to comorbidity and supports 
the role of poor sleep as a risk factor for fatigue. 
Fatigue is usually considered in the context of cancer 4, 6, 12, 24, 31, or chronic disease 32-38, 
although it impacts other populations as well. While a common complaint in older adults, it has 
rarely been addressed as a specific outcome in studies of this population. Studies performed in 
younger cohorts have reported fatigue symptoms in 12-25% of the population 16, 39, 40. In one 
group of older adults, living in an assisted living facility, over 50% these individuals exhibited at 
least mild fatigue 10. In addition to the dissimilar population groups assessed in these studies, the 
use of multiple, non-standardized fatigue scales makes it difficult to compare the fatigue rates 
found in the Health ABC cohort with these other studies. However, over 37% of the Health ABC 
cohort had a fatigue score ≥20 that would indicate a mild-moderate fatigue level. 
To fully differentiate fatigue from sleepiness is difficult since sleepiness is often used to 
define fatigue 8. Removal of the question “How sleepy are you during the day” from the total 
fatigue score, in this study, did not change the associations found between disturbed sleep and 
total fatigue. Fatigue has been associated with a wide range of sleep disorders and behaviors 
however, the causes of fatigue in sleep disordered populations is relatively unknown 1, 24, 28. In 
individuals referred to sleep clinics, subjective fatigue has been shown to be independent of sleep 
disorder severity and daytime sleepiness in 1, 15, 27, 41. Results of this study suggest an independent 
association of self-reported disturbed sleep and fatigue.  
The direct association of chronic health conditions with fatigue in this population cannot 
be disregarded. Unlike tiredness, fatigue in chronic illness is pervasive and multi-dimensional, 
with different perceived causes and implications 2, 29. In this study self-reported health status, 
cardiopulmonary disease, dyspnea, and depression were also strong associates of fatigue, even 
after adjustment for other variables. These associations were consistent with known associations 
of fatigue and medical comorbidities reported in other populations 3, 7, 10, 26, 28, 40, 42. To what 
extent chronic disease might cause fatigue; or chronic disease might cause disturbed sleep which 
in turn causes fatigue, is not well defined even in cancer in sleep apnea patients. Results from 
this study suggest poor sleep has an independent contribution. 
This study had several limitations. The study was cross-sectional representing one point 
in time; therefore a temporal relationship between sleep and fatigue cannot be determined. 
Fatigue is a subjective syndrome and there is no gold standard to assess it. Various other fatigue 
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scales, or components of scales, currently in use may provide different correlates of fatigue 6. 
Usual sleep time and sleep behaviors were obtained by self-report. Although the validity of self-
report sleep data has been demonstrated with actigraphy 43 some variability between actual and 
self-report exists. This study was of community dwelling older adults and may not be similar in 
other populations.  
In summary, the results of this study of well-functioning community dwelling older 
adults suggest that fatigue was associated with several aspects of sleep including long sleep 
duration, frequent napping, and disrupted sleep independent of other health-related conditions 
commonly associated with fatigue. Part of this association may be explained by poorer self-
reported health status. Improvement in nighttime sleep patterns and self-perceived health status 
may improve fatigue symptoms in community dwelling older adults. 
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Table 3-1 Participant characteristics at the Health ABC year 5 (2001-2002) clinic visit 
 Men 
n = 1078 
(47.6%) 
Women 
n = 1186 
(52.4%) 
Total 
N=2264 
Demographics:    
Age (years) mean(sd) 77.7 (2.8) 77.3 (2.9) 77.5(2.9) 
Race    
  Black % 32.1 41.9 37.2 
  White % 67.9 58.1 62.8 
Average Fatigue Score 16.8 (8.3) 18.5(8.5) *** 17.7 (8.4) 
Self-reported sleep variables: n(%) n(%) n(%) 
Sleep Duration:    
  ≤ 6hrs   (n=857) 35.4 40.0 37.9 
     7 hrs   (n=628) 27.9 27.6 27.7 
     8 hrs    (n=619) 28.9 25.9 27.3 
  > 8 hrs (n=160) 7.7 6.5 7.1 
Naps ≥7/wk  % 37.5       28.9 *** 33 
Trouble falling asleep (> 1night/mo)% 33.9      46.2 *** 40.3 
Wake up during night(> 1night/mo)% 48.1    54.0 ** 51.2 
Wake up too early (> 1night/mo)% 37.0  41.4 * 39.3 
Sleep medications (> 1night/mo)% 10.6    14.6 ** 12.7 
Health variables:    
BMI (kg/m2):    
   BMI < 25 (kg/m2) % 31.4 35.2 33.4 
   BMI 25 - 30 (kg/m2) % 47.5 35.2 41.1 
   BMI >30 (kg/m2) % 21.2 29.5 25.5 
Self reported health status:    
  Excellent (n=240) 11.7 9.6 10.6 
  Very good (n=733) 33.3 31.6 32.4 
  Good (n=865) 36 40.3 38.2 
  Fair – Poor (n=424) 19.1 18.5 18.7 
Stroke (n=81) 4.0 3.2 3.6 
Coronary heart disease (n=316) 17.5      10.7 *** 14 
Congestive heart failure (n=166) 7.8 6.9 7.3 
Dyspnea (n=798) 29.1       41.1 *** 35.4 
Depression (mean(SD)) 4.4 (4.0)               5.5(4.6) *** 5.0 (4.3) 
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 Men 
n = 1078 
(47.6%) 
Women 
n = 1186 
(52.4%) 
Total 
N=2264 
kcal/kg/wk walking + climbing stairs: 
    <0.03 (n=381) 
 
16.8 
 
       26.2 *** 
 
21.8 
      0.03 - ≤1.23 (n=648) 23.3 28.8 26.2 
   >1.23 - ≤5.53 (n=617) 27.3 24.7 25.9 
   >5.53 (n=618) 32.6 20.4 26.1 
 
*    p≤ 0.05 
**  p ≤ 0.01 
**  p ≤0.001 
 
Table 3-1cont. 
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Table 3-2 Correlation of the fatigue scale components to the total fatigue score and symptoms of 
disturbed nighttime sleep (Spearman’s rho rs ) in Health ABC year 5 (n=2264)  
 
 
 
1 TFS = trouble falling asleep at night; WUDN = wake up during the night; WUTE = wake up too early; 
MEDS = use of medication to help sleep. Questions were asked on an ordinal Scale 0= never, 1 = ≤ 
once/month; 2 = 2-4 times/month; 3= 5-15 times/month 4 = 16 – 30 times/month. 
2 Scale of 0 – 10 (worst) over the past month 
3 Correlations reported for direction the question was asked. When part of the fatigue scale they were 
reversed.  
4 Total fatigue score (see methods section). 
5 Total fatigue score made up of the following questions: How weak did you feel, how lively did you feel, 
how tired did you feel, and describe your usual energy level. 
 ** <0.001   
*** <0.0001 
 Nighttime Sleep Behaviors 
Fatigue Scale Components  TFS1 WUDN1 WUTE1 MEDS1 
During the past month how:     
Weak did you feel ?2 0.13*** 0.19*** 0.16*** 0.12*** 
Sleepy did you feel during day ?2 0.07** 0.17*** 0.14*** 0.05** 
Lively did you feel ?2,3 -0.13*** -0.14*** -0.17*** -0.13*** 
Tired did you feel ?2 0.15*** 0.18*** 0.17*** 0.10*** 
Describe your usual energy level. 2,3 -0.11*** -0.18*** -0.18*** -0.10*** 
Total fatigue score (5 item scale)4 0.15*** 0.23*** 0.22*** 0.14*** 
Total fatigue score (4 item scale)5 0.16*** 0.23*** 0.22*** 0.15*** 
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Table 3-3 Factors associated with fatigue in multivariable models adjusted for age, race and gender and fully adjusted 
  
 Percentage difference in fatigue per unit (95% CI) 
Variable 
 
Mean (SD) or 
prevalence (%) 
Unit/ 
Referent1 
Adjusted model (age, race, 
and gender) 
Fully adjusted model 1 
Age (years)  77.5 (2.9) 1 0.6 (-0.1, 1.3) 0.3 (-0.3, 0.9) 
Gender: Female  52.4 % Male 10.0 (6.1, 13.9 ) 3.2 (-0.2, 6.6) 
Race:    Black 37.2 % White 0.4 (-3.6, 4.5) -11.9 (-15.4,-8.2) 
 Sleep Duration:      
  ≤ 6hrs   37.9 %  15.4 (10.5, 20.2) 4.2 (-0.01, 8.3) 
     7 hrs   27.7 % Referent   
     8 hrs   27.3 %  3.6 (-1.6, 8.8) 3.2 (-1.2, 7.6) 
  > 8 hrs   7.1 %  8.5 (0.4, 16.7) 7.2 (0.2, 14.3) 
Trouble falling asleep >1night/mo  40.3 %  11.5 (7.5, 15.5) -3.9 (-7.7, 0.2) 
Wake up during night >1night/mo  51.2 %  19.6 (15.8, 23.5) 5.8 (2.0, 9.6) 
Wake up too early    > 1night/mo  39.3 %  20.4 (16.5, 24.3) 6.3 (2.4, 10.1) 
Sleep medications    > 1night/mo  12.6 %  16.9 (11.0, 22.8) 1.3 (-3.8, 6.3) 
Self-reported health status:     
     Excellent 10.6 % referent   
    Very Good 32.4 %  17.0 (10.7, 23.2) 10.8 (5.1, 16.6) 
     Fair 38.2 %  37.8 (31.6, 44.0) 23.7 (17.9, 29.5) 
     Poor 18.7 %  66.5 (59.6, 73.5) 38.4 (31.3, 45.2) 
Cardio-pulmonary disease2:   
   1 disease 
 
13.7% 
 
 
 
12.5 (6.8,18.2) 
 
4.2 (-0.8, 9.2) 
   2 + diseases 5.4%  23.7 (15.1, 32.3) 13.1(5.4, 20.7) 
   
 57
 Percentage difference in fatigue per unit (95% CI) 
Variable 
 
Mean (SD) or 
prevalence (%) 
Unit/ 
Referent1 
Adjusted model (age, race, 
and gender) 
Fully adjusted model 1 
Dyspnea (any symptoms) 35.4%  31.2 (27.3, 35.1) 14.0 (10.3,17.8) 
Depression 5.0 (4.3) 1 SD 101.0 (93.6, 108.5) 69.6 (61.5, 77.6) 
kcal/kg/wk walking + climbing 
stairs: 
    
     0.03 - ≤1.23 (n=648) 26.2% <0.03 -6.1 (-11.9, -0.4) 3.3 (-1.5, 8.0) 
   >1.23 - ≤5.53 (n=617) 25.9%  -13.6 (-19.4, -7.8) -0.7 (-5.6, 4.2) 
   >5.53 (n=618) 26.1%  -24.3 (-30.2, -18.5) -7.2 (-12.2,4.2) 
    model r2  0.36 
 
1 Referent group is group with none of the characteristic. 
2 Cardiopulmonary disease includes congestive heart failure, coronary heart disease, and/or stroke.
Table 3-3 cont. 
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4.1 ABSTRACT 
Study objectives: Daytime sleep (napping) might indicate deficiencies in nighttime 
sleep, but the relationship is not well defined. This study assessed the association of 
nighttime sleep duration and fragmentation with daytime sleep in community dwelling 
older adults. 
Design: Cross-sectional study. 
Participants: 235 individuals (47.5% men, 29.7% black), age 80.1(2.9) years. 
Measurements and Results: Nighttime and daytime sleep were measured with wrist 
actigraphy (Actiwatch AW-16®, Mini Mitter, Inc.) and sleep diaries for an average of 
6.8(0.7) nights. Sleep parameters measured included total nighttime sleep (hrs), 
movement and fragmentation index (fragmentation), and total daytime sleep (nap) (hrs). 
The relationship of total nighttime sleep and fragmentation to napping (yes/no) was 
assessed using logistic regression. In only the individuals who napped, mixed random 
effect models were used to determine the association between the previous night sleep 
duration and fragmentation and nap duration, and nap duration and subsequent night 
sleep duration. All models were adjusted for age, gender, race, BMI, cognitive status, 
depression, number of times waken during the night, cardiovascular disease, respiratory 
symptoms, pain, and fatigue. Naps were recorded by 178(75.7%) participants. The odds 
of napping were higher for individuals with high levels of nighttime fragmentation, 
diabetes, and pain (2.8 (95% CI, 1.1, 7.1), 5.9 (1.2, 28.9), and 2.3 (1.1, 4.8) respectively). 
In the group that napped neither sleep duration nor fragmentation the night before the nap 
was associated with nap duration the next day.  
Conclusion: Higher nighttime sleep fragmentation was associated with higher odds of 
whether or not an older adult naps, however it was not associated with nap duration 
within nappers. The identification of causes and methods to reduce fragmented sleep may 
help lessen daytime napping in older adults. 
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4.2 INTRODUCTION 
Daytime sleep (napping) and frequent nocturnal awakenings are sleep changes associated 
with aging 6, 10, 12, 17, 37, 62, 91, 174, 175. The relationship between nighttime sleep and napping 
in older adults has been determined primarily by self-report, or from laboratory studies in 
small groups of individuals. The association of measured nighttime sleep patterns with 
measured daytime napping, and measured daytime napping on measured nighttime sleep, 
is unclear 41, 96, 140. Some studies have shown napping to have little impact on subsequent 
night sleep quality or duration 62, 96, 98 while another reported a negative impact on sleep 
quality and duration in the subsequent nights 41. 
In active community-dwelling older adults the association between disturbed 
nighttime sleep and whether an individual takes a nap during the day is not well defined. 
Further, the temporal relation between disturbed nighttime sleep and daytime napping is 
unclear. The study’s objectives were to determine sleep behaviors and other factors 
associated with taking a nap in older adults; and to evaluate the association with daytime 
nap duration. This study hypothesis was shorter nighttime sleep duration, and higher 
amounts of fragmentation would be associated with higher odds for taking a nap, as well 
as with longer nap duration. It also hypothesized a longer daytime nap would be 
associated with a shorter nighttime sleep on the nap night. 
4.3 METHODS 
4.3.1 Study Population 
Participants were a subgroup from the Pittsburgh site of the Health Aging and Body 
Composition (Health ABC) study at the eighth year (2004–2005) clinic visit who agreed 
to participate in a sleep study where they would wear a wrist actigraph continuously for 
one week and complete a 24 hour sleep-wake diary at bedtime and wake time. The Health 
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ABC study was designed to evaluate the relationship between weight, body composition, 
and various health conditions in community dwelling older adults. The study enrolled 
3075 adults aged 70–79 years, 42% black, and 52% women between 1996–1997 in 
Pittsburgh PA, and Memphis TN. Individuals were excluded if they reported difficulty 
walking a quarter of a mile, climbing 10 steps without resting, or with activities of daily 
living. They were also excluded if they had cancer under active treatment within the past 
3 years, or planed to move within 3 years.  
Participation in the sleep study was voluntary and offered to participants based on 
availability of a wrist actigraph during their study visit. Participants were excluded if they 
would not be able to wear the watch and/or complete the diary, used CPAP or oxygen at 
night, were cognitively impaired, were undergoing treatment for cancer, or if they had 
any end-stage disease. Two hundred and thirty six individuals wore wrist actigraphs and 
successfully completed the daily sleep-wake diary. The nap duration on two days for one 
participant exceeded seven hours. It was subsequently determined she was ill and was 
hospitalized on the sixth day of the study. She was removed from the analyses. The 
institutional review board at The University of Pittsburgh approved the study and written 
informed consent was obtained from all participants. 
4.3.2 Sleep  
Nighttime and daytime sleep was measured by actigraphy with the Mini-Mitter 
Actiwatch® (AW-16). The actiwatch was worn on the non-dominant wrist over 7 
consecutive 24 hour periods starting at the clinic visit. The wrist actiwatch monitors gross 
motor activity and was set to record in one minute epochs at a medium sensitivity level 
for scoring sleep and wake times (40 activity counts/minute) 176, 177. Participants were 
given a sleep-wake diary to complete concurrent with wearing the watch. Daily they 
recorded the time they: went to bed, tried to go to sleep, woke up in the morning, got out 
of bed in the morning, number of times they awoke during the night; and the start time 
and end time for each daytime nap ≥5 minutes. To differentiate nap time from periods of 
inactivity there was a separate entry on the daily form for periods of sitting still for over 
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an hour such as watching television, reading, and riding in a car. All participants were 
instructed in the use of the wrist actigraph and how to complete the sleep-diary during 
their clinic visit. Phone support was available to the participants throughout the study. 
Data from the wrist actigraphs were downloaded to a personal computer and 
analyzed with Mini-Mitter® version 5 software using a validated algorithm, set at medium 
sensitivity, to identify sleep and wake 176. The threshold for medium sensitivity is 40 
activity counts. Nighttime sleep and morning wake times were set based on review of the 
downloaded actogram and verified against the time recorded in the participants’ diary. If 
>5 minute discrepancy occurred between the actogram and the diary the actogram time 
was used. To determine if a participant took a nap, as well as the duration of the nap, nap 
intervals were only set on the actogram if the participant had entered a start and stop time 
for the nap in their sleep-wake diary. One individual read all of the actograms with an 
intra-reader reliability >0.95 based on a random sample of 10 participant actograms. 
Sleep and nap measurements were calculated with Mini-Mitter® V5 software. 
The total nighttime sleep duration was the sum of all sleep epochs within the interval 
between set sleep and set wake time. Wake after sleep onset was measured as the sum of 
all wake epochs during the sleep period. The movement and fragmentation index 
consisted of the sum of the percent of mobile minutes and the percent of immobile bouts 
less than 1 minute duration to the number of immobile bouts, for a given interval, 
hereafter referred to as fragmentation. Daytime sleep was scored the same as the total 
duration of nighttime sleep 176. 
Self reported sleep duration and nap behavior in a typical week were determined 
by participant response to the questions: “How many hours of sleep do you usually get at 
night?”, and “During a usual week, how many times do you nap for 5 minutes or more?” 
To determine problems with nighttime sleep participants were asked the following 
questions on a 5-point Likert scale: During a typical month how often do you have:  
Trouble falling asleep?”; “Wake up during the night and have difficulty getting back to 
sleep?”; “Wake up too early in the morning and are unable to get back to sleep?”; and 
“Take sleeping pills or other medication to help you sleep?”. Response options to these 
questions were: never, ≤once a month, two to four times a month, five to 15 times a 
month, and >15 times a month. For analysis, these variables were collapsed into: 
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“infrequent” consisting of never and ≤once per month and “frequent” ≥2 times per 
month. 
4.3.3 Demographics and General Health 
At the eighth annual clinic visit a detailed interview and exam was conducted to obtain 
and update demographic and health history. Data obtained included age, sex, race, height, 
weight, socio-economic variables, history of diseases, and medications.  
4.3.4 Outcome 
At the eighth annual clinic visit a detailed interview and exam was conducted to obtain 
and update demographic and health history. Data obtained included age, sex, race, height, 
weight, socio-economic variables, history of diseases, and medications. 
4.3.5  Comorbid health conditions 
Cardiovascular disease was defined as history of myocardial infarction, angina, stroke, 
transient ischemic attack, or congestive heart failure at the sixth year Health ABC visit, 
an average of two years prior to the current one. Unfortunately, this data was not 
available for the same time period as the sleep study. Due to the low incidence of each 
individual disease in the sleep study cohort, a summary cardiovascular disease variable 
was developed to represent the presence or absence of any one of the diseases. Diabetes 
was defined by self-report of the disease at the eighth year visit. Respiratory disease was 
defined as self-report of any of the following: dyspnea on exertion, need to stop for 
breath when walking, history of asthma, chronic obstructive pulmonary disease, 
emphysema, or bronchitis. Similar to cardiovascular disease a summary variable was 
created that represented presence or absence of any of the symptoms. Depression was 
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measured with the 10 item Center for Epidemiologic Studies Depression scale 159 was 
used to measure depression.  
4.3.6 Other potential confounders 
Factors associated with napping considered as potential confounders, or mediators, 
previously identified associated with sleep or nap 1, 13-15, 175 and included: body mass 
index (BMI) (kg/m2); self-reported health status (excellent-good, fair, poor); mental 
status (Teng Mini-Mental Status Exam); smoking (yes or no); or use of alcohol. Pain was 
defined as a response of yes to the question, “have you experienced any bodily pain in the 
past 30 days”. Fatigue was evaluated with a subscale from the Piper Modified Fatigue 
Scale (scale 0-50 highest) 44, 66. Due to the low prevalence of smoking (n (%) 4(2)) it was 
not included in the analyses. 
4.3.7 Statistical analyses 
Participants were classified into those who napped, or did not nap, based on whether a 
nap interval was recorded on any day in the sleep-wake diary. Student t-tests were used to 
test differences in means between dichotomous variables, and chi-square analysis was 
used for categorical variables between individuals who did or did not nap. A series of 
logistic regression models were performed to obtain the odds ratios for taking or not 
taking a nap. Models were adjusted for variables associated with either sleep or nap in 
univariate analysis, or that have been reported in the literature 1, 13-15, 175. The final model 
included age, race, BMI (kg/m2), measured night time sleep (hrs), measured movement 
and fragmentation, depression, mental status, pain in the past 30 days, cardio-pulmonary 
disease, respiratory disease, diabetes, and fatigue. Measured movement and 
fragmentation was evaluated as a continuous variable, as well as divided into tertiles.  
In those participants who recorded naps mixed models were fit to determine the 
association of the previous night measured sleep duration and fragmentation with the next 
day measured nap duration. Also evaluated in this group was the association of the 
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previous night measured sleep duration, fragmentation, and the next day measured nap 
duration on the measured sleep duration for the night of the nap. Participant was the 
random effect in the models and the same variables considered in the logistic regression 
models above were considered as fixed effects in the mixed models.  
Linear regression models were also performed, in those who reported naps, to 
determine the association between the average nighttime sleep duration and average 
fragmentation with the duration of the average daytime nap over the time period the 
participant wore the wrist actigraph. Variables considered in the logistic and mixed-
model analyses described above were evaluated here as well. To express the strength of 
the associations, units of percent differences were calculated from the regression 
coefficients with the formula (beta*unit/mean nap duration (hrs)) 163. All analyses were 
run in STATA version 8 (Stata College Station, TX), or SAS version 8 (Cary, NC). 
Analyses were considered significant at p≤0.05 unless otherwise noted. 
4.4 RESULTS  
Wrist actigraphs were worn for an average 6.8(0.7) (mean (SD)) nights, with a nap of ≥5 
minutes recorded by 178(75.7%) participants. The average age of those who recorded 
naps was 80.1(2.9) years, 92(51.7%) were women, 86(48.3%) were men, 124(69.7%) 
were white and 111(30.3%) were black. Basic demographic characteristics were similar 
between those who did or did not record a nap. Those who napped recorded an average of 
3.9(2.6) naps over the period they wore the watch, with an average nap duration of 
1.1(0.6) hours/nap. Average nighttime sleep duration, measured by actigraphy, was 
similar between the individuals who napped or did not nap. Individuals who napped had 
higher nighttime fragmentation, as measured by both the movement and fragmentation 
index and wake after sleep onset (Table 4.1). 
Self-reported hours of sleep per night, trouble falling asleep, waking up during the 
night, waking up too early in the morning, using medications to help sleep, or daytime 
sleepiness did not differ between those who did or did not record naps. The self-reported 
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number of naps per week and fatigue score was higher in those who recorded naps. 
Higher percentages of individuals who recorded naps also reported pain over the past 30 
days, respiratory symptoms, or diabetes (Table 4.1).  
In unadjusted logistic regression models, to identify potential determinants for 
having recorded a nap, odds of recording a nap were higher for individuals with higher 
levels of fragmentation, symptoms of pain in the past 30 days, respiratory symptoms, 
diabetes, or higher fatigue levels. In the fully adjusted model individuals with pain over 
the past 30 days, respiratory symptoms, diabetes and higher fatigue score had higher odds 
for napping that were not attenuated by adjustment. Individuals with fragmentation in the 
second tertile (28–40) had slightly higher odds of having recorded a nap after full 
adjustment, while the odds for napping in those individuals in the third tertile (≥ 40) were 
slightly attenuated (Table 4.2). 
In individuals who recorded a nap, the temporal relationship between the previous 
night measured sleep duration and fragmentation with the next day measured nap 
duration was evaluated first with separate linear regression models using specific 
sequential night-day intervals. In two separate sequential intervals, although not 
significant, there was a pattern where shorter nighttime sleep, and more nighttime 
fragmentation, was associated with longer daytime nap duration (Table 4.3).  
The association between the measured previous nighttime sleep duration and 
fragmentation with the next day nap duration was examined further with mixed model 
analysis. Neither of these sleep variables were associated with nap duration the next day 
(Table 11). In the fully adjusted mixed model variables associated with nap duration were 
self-report of pain in the past 30 days (22.4% shorter nap duration), black race (25.9% 
longer nap duration), and self-reported diabetes (34.9% longer nap duration) (Table 4.4). 
The association between the measured previous night sleep duration, 
fragmentation, and next day nap duration with the next night measured sleep duration 
was examined with mixed model analysis in the individuals who napped (Table 4.5). 
Neither previous night sleep duration, nor fragmentation, were significantly associated 
with sleep duration the next night. Every hour of daytime sleep (nap) however, was 
associated with 7.5% less sleep duration on the night of the nap. The previous night sleep 
duration X daytime sleep duration interaction was significant. However, the 0.8% higher 
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nighttime sleep duration associated with the interaction would have minimal effect on 
overall sleep duration.  
Linear regression models were performed to determine the association of 
measured sleep duration, fragmentation with nap duration averaged over the time period 
the wrist actigraph was worn. In the fully adjusted model self report of body pain was 
associated with shorter nap duration and diabetes with longer nap duration (Table 4.6). 
Fragmentation while strongly associated with the odds for napping was not associated 
with nap duration either as a continuous variable or by tertile. 
4.5 DISCUSSION 
Higher nighttime fragmentation, measured by wrist actigraphy, was associated with up to 
3.2(95%CI 1.1, 7.1) times higher odds of recording a nap in this cohort of 80 year old 
adults. This association remained after adjustment for age, race, gender, and measured 
nighttime sleep duration (hours). Further adjustment for self-reported use of sleep 
medication, BMI, depression, cognitive status, pain, respiratory symptoms, 
cardiopulmonary disease, diabetes and fatigue did not attenuate this finding. In the 
individuals who recorded naps, longer nap durations were associated with self-report of 
diabetes and shorter nap durations were associated with self report of pain. Longer nap 
durations were not, however, explained by either the average measured sleep duration or 
nighttime fragmentation over the time period the participants wore the wrist actigraph.  
Fragmentation was the nighttime sleep measurement that differentiated 
individuals who reported naps from those who did not. Frequent nighttime awakenings in 
older adults have been reported  in multiple studies  6, 10, 91, 93, 147, 174, 175, 178. These 
arousals have been associated with reduced daytime well-being, daytime sleepiness, and 
napping 93, 147, 178, 179. This study supports prior research and corroborates the association 
between fragmented nighttime sleep and daytime napping. In addition, we were able to 
demonstrate that higher levels of fragmentation were associated with higher odds of 
having taken a nap. Neither measured nighttime sleep duration, nor fragmentation was 
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associated with recorded nap duration. While this may be attributable to lack of power, 
this lack of association still requires further investigation. 
A major factor associated with nighttime fragmentation, not measured in this 
study is sleep disordered breathing, or obstructive sleep apnea. Use of the movement and 
fragmentation index, does however, provide an estimate of sleep apnea syndrome, or 
sleep disordered breathing. This index has been shown to be highly correlated (r=0.98) 
180, and to have high sensitivity and specificity, 89% and 95% respectively 181 with 
polysomnography (PSG) to measure sleep apnea syndrome (or sleep disordered 
breathing). 
Sleep disordered breathing, defined as an apnea-hypopnea index (AHI) ≥10-15, 
has been estimated to range from 45-62% in adults ≥60 years 180, 181. Fifty nine percent of 
participants in this study had a movement and fragmentation index ≥30, a value 
associated with severe sleep apnea syndrome in a patient population with a mean age of 
52±15 years 180. This suggests a large portion of these individuals might have some form 
of undiagnosed sleep disordered breathing that might be amenable to treatment. 
Self- reported diabetes and pain were the conditions most highly associated with 
nap duration. A higher risk for diabetes has been associated with short (<6 hours) or long 
(>9 hours) sleep duration 100, 148, 182, 183. Diabetes has also been associated with excessive 
daytime sleepiness 148, 184, however whether or not diabetics actually take a nap has not 
been demonstrated. This study extends the relationship and suggests an association 
between diabetes and napping as well.  
To make an overall association between napping and general health in this 
population is unequivocal based on our data. We found no association with cardio-
pulmonary diseases, however a strong association was found with self reported diabetes. 
The lack of association with cardiovascular disease differs from reports in other 
populations of older adults where not only was a siesta more common in individuals with 
a past history of myocardial infarction, but the siesta was predictive of cardiovascular 
disease 185, 186. However, it must be noted that the measure of cardiovascular disease ,in 
this study, represents disease status two years earlier and might not reflect current disease 
status.  
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A recent review of the role of napping in sleep medicine concluded that there was 
not enough evidence accounting for the association between napping and health risks 97. 
Napping in old age has been suggested to help older adults maintain their daytime 
functioning at an adequate level 97, 102. However, napping has also been associated with 
an increase in mortality  104, 140, 185. 
Whether or not older adults should nap or avoid napping is debatable. A daytime 
nap has been associated with activity-related health deficits and poor sleep hygiene 104 
and avoiding it to improve nighttime sleep has been advised 55. However, napping as 
away to increase 24 hour sleep quality, duration, or to offset insomnia has also been 
suggested 41, 55, 96. Our study demonstrated that total sleep time was significantly higher 
on the days that the study participants recorded a nap. A short nap can improve alertness 
after restricted sleep 97, 102, 187  Napping, as well as the ability to fall asleep, has been 
shown to be more common in older adults with a good night’s sleep compared to those 
with a poor night sleep 96, 148 and it was not restricted to those complaining of insomnia .  
Several limitations in interpreting these data warrant discussing. The participants 
represent a survival cohort of the original Health ABC study of community dwelling 
older adults. The individuals in this ancillary study were primarily individuals still active 
and participating in daily events. As such, poorer functioning or institutionalized older 
adults are not represented in this sample. Measurements of nighttime and daytime sleep 
were obtained by actigraphy in conjunction with self report and might differ from 
polysomnography measured sleep. Further, as naps were only measured if recorded this 
might result in underestimation of napping in the population. Finally, cardiovascular 
status was determined based on disease status 2 years earlier and diabetes and respiratory 
symptoms were measured by self-report. This might underestimate the incidence of these 
diseases in our cohort and bias the results towards shorter nap duration. 
These findings have important clinical implications and point to the need for 
health care providers to discuss nighttime and daytime sleep characteristics with their 
older patients. This study showed that nighttime fragmentation was associated with 
higher odds of whether or not an older adult took a nap during the day. Research to 
reduce causes of fragmented nighttime sleep in older adults might help reduce the 
number of naps taken in community dwelling older individuals. 
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Table 4-1 Characteristics of Health Aging and Body Composition sleep study participants by 
napping status (N=236). 
 
 No Recorded Naps (n=57) Recorded Naps (n=178) 
 mean (SD) mean (SD) 
Age (yr) 80.2 (2.8) 80.1 (2.9) 
BMI (kg/m2) 28.0 (5.2) 28.1 (4.2) 
Self report number of naps/week 1.6 (2.2) 5.3 (4.7)*** 
Self report hours of sleep/night 6.9 (1.4) 6.7 (1.4) 
Nap duration (hrs)1 0 0.6 (0.5) 
Nighttime sleep (hrs) 1 7.6 (1.0) 7.5 (1.1) 
Movement & Fragmentation Index 1 31.0 (11.4) 37.7 (15.2) ** 
Wake after sleep onset (hrs) 1 0.9 (1.0) 1.0 (0.5) * 
Number of times up at night (sleep diary) 1.7 (1.2) 1.8 (0.9) 
Mental Status (Teng 3 MS) 93.7 (5.2) 92.8 (5.9) 
Depression (CES D10) 4.5 (4.0) 4.6 (3.7) 
Fatigue (scale 0-50)2 15.0 (7.9) 18.2 (7.6)** 
 n (%) yes n (%) yes 
Gender – Male     (n=112) 
             -  Female (n=124) 
26 (45.6) 
31 (54.4) 
86 (48.3) 
92 (51.7) 
Race – White (n=166) 
        -   Black (n=70) 
42 (73.7) 
15 (26.3) 
124 (69.7) 
54 (303) 
Trouble falling asleep 3 23 (40.4) 74 (41.6) 
Wake up during the night 3 23 (40.4) 96 (54.2) 
Wake up too early 3 24 (42.1) 77 (43.5) 
Use medicine to help sleep 3 8 (14.0) 17 (9.6) 
Daytime sleepiness 3 25 (43.9) 87 (48.8) 
   
Movement & Fragmentation Index (Tertiles) 
             < 28 
             ≥ 28 - <40 
             ≥ 40  
 
27 (47.4) 
19 (33.3) 
11 (19.3) 
 
51 (28.7) 
60 (33.7) 
67 (37.6) * 
Alcoholic beverages (any) 33 (57.9) 84 (47.5) 
History of falling in past year  17 (29.8) 53 (29.8) 
Pain past 30 days  31 (54.4) 127 (71.4) *** 
Respiratory symptoms4 16 (28.1) 81 (46.0) ** 
Cardiovascular disease  5 5 (8.8) 28 (15.7) 
Diabetes (self report) 2 (3.9) 30 (18.8) ** 
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Table 4.1 cont. 
1 Measured with actigraphy. All values represent average duration for the period the participant wore the 
watch. 
2 Actual range was 0 – 38. Population median = 18. 
3 Self report: less than one time per month, or more than one time per month. 
4 Self-report of any of the following: dyspnea on exertion, need to stop for breath when walking, history of 
asthma, chronic obstructive pulmonary disease, emphysema, or bronchitis. 
5 History of myocardial infarction, angina, stroke, transient ischemic attack, or congestive heart failure at 
the Health ABC year six visit (average of two years earlier). 
*p =0.05 
**p ≤ 0.01 
***p≤0.001 
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Table 4-2 Odds of taking a daytime nap in the Health Aging and Body Composition Sleep Study (n = 235)1  
 
 
1 Only variables with a significance level of p ≤ 0.10 in univariate, logistic or regression models are shown here. 
2 Adjusted for age, race, gender, total night time sleep (hrs), and tertile of movement and fragmentation index, self reported use of sleep medications, self-report 
of pain in the last 30 days, cardiovascular disease at the Health ABC year six visit, self-reported respiratory symptoms, self-reported diabetes, depression score, 
mental status, and fatigue. Units for continuous variables approximate 1 standard deviation; for dichotomous variables, the referent group does not have the 
characteristic. 
4 Measured with Mini Mitter® AW-16 and Actiware ® v5 software
 Unit/Referent Unadjusted Adjusted – Sleep2 Fully Adjusted Model3 
  OR (CI) OR CI OR CI 
Race White 1.2 (0.6, 2.4) 1.1 (0.6, 2.2) 1.1 (0.4, 2.7) 
Gender Male 0.9 (0.5, 1.6) 1.0 (0.6, 2.0) 1.1 (0.5, 2.4) 
Night time sleep duration4  Hour 0.9 (0.7, 1.2) 0.9 (0.7, 1.2) 0.8 (0.5, 1.1) 
Movement and fragmentation (tertile)  4      
                          28 – 40 
                         ≥ 40 
< 28   
1.7 
3.2 
 
(0.8, 3.4) 
(1.5, 7.1) 
 
1.8 
3.3 
 
(0.9, 3.5) 
(1.5,7.3) 
 
1.9 
2.8 
 
(0.8, 4.5) 
(1.1, 7.1) 
Depression score  3.8 1.0 (0.8, 1.4) 1.0 (0.7, 1.2) 0.7 (0.5, 1.1) 
Pain past 30 days (n=128) None 2.1 (1.1, 3.9) 2.1 (1.1, 40) 2.3 (1.1, 4.8) 
Respiratory symptoms (n = 98) None 2.2 (1.1, 4.2) 2.3 (1.1, 4.8) 2.4 (1.1, 5.3) 
Diabetes  (n=32) None 5.8 (1.3, 25.0) 5.1 (1.1, 22.7) 5.9 (1.2, 28.8) 
Fatigue score 7.7 1.5 (1.1, 2.1) 1.5 (1.1, 2.1) 1.6 (1.0, 2.5) 
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Table 4-3  Regression models showing the temporal association of measured nighttime sleep duration and fragmentation  
with daytime sleep (nap) duration  in Health ABC sleep study participants who recorded naps  (n=178) 
 
Independent Variable Percentage difference in nap duration per unit 
(95% CI)  (First randomly selected night-day  
interval)  
Percentage difference in nap duration per unit 
(95% CI)  (Second randomly selected night-day 
interval)  
Previous night sleep duration (hr) -3.7 (-10.62, 3.48) -2.3 (-9.5, 4.9) 
Previous night movement and fragmentation1 -49.6 (-173.8, 74.6) -38.8 (-153.4, 75.9) 
   
 
1 Standardized per unit of 1 standard deviation =14.6. 
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Table 4-4 Multivariable associates of nap duration in the Health ABC sleep study participants who reported naps (n = 159).  
 
Variable Unit/ 
referent 
Percentage difference in nap duration 
per unit  (95% CI) (unadjusted) 
Percentage difference in nap duration per 
unit (95% CI) fully adjusted model 1 
Gender Male -3.3 (-19.5, 27.3) -2.7 (-22.7, 36.8) 
Race  White 18.3 (0.4, 76.7) 25.9 (4.3, 100.5) 
Previous night sleep duration (hrs)  Hour -3.7 (-7.5, 0.2) -2.4
 (-6.5, 3.8) 
Previous night - Movement and fragmentation   14.63 -28.5 (-97.2, 40.2) -8.5 (-86.0, 69.1) 
Depression score 3.76 20.9 (-11.0. 52.8) 37.3 (-1.9, 76.4) 
Mental State  5.8 -23.8 (-70.0, 22.3) -1.7 (-53.7, 50.4) 
Bodily pain last 30 days None -14.2 (-31.9, 7.4) -22.4 (-42.8, -4.3) 
Respiratory symptoms None -9.1 (-25.6, 15.5) -6.3 (-24.9, 30.0) 
Self reported diabetes None 34.1 (11.9, 119) 34.9 (11.0, 124.5) 
Fatigue  7.7 24.9 (-39.8, 89.6) 24.0 (-53.2, 103.2) 
 
1 Fully adjusted mixed model included nighttime sleep duration (hours from actigraphy), movement and fragmentation index (nightly actigraphy), age (years), 
race, gender, BMI (kg/m2), depression, mental status, bodily pain in the last 30 days (yes/no), cardiovascular disease at the year 6 visit (yes/no), self-reported 
respiratory symptoms (yes/no), self-reported diabetes (yes/no), self reported number of  times up each night, fatigue score. Units for continuous variables 
approximate 1 standard deviation; for dichotomous variables, the referent group does not have the characteristic. 
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Table 4-5 Multivariable associates of previous night sleep and nap duration on nap night sleep duration using mixed model analysis in Health ABC 
sleep study participants who reported daytime nap (n = 159) 1     
 
Variable 
Unit/ 
Referent 
Percentage difference in nighttime sleep 
duration1 per unit  (95% CI) 
(unadjusted) 
Percentage difference in nighttime sleep 
duration1 per unit (95% CI) adjusted for 
multiple variables2 
Race White -4.4 (-9.3, 0.5) -7.4 (-13.4, -1.4) 
Gender Male -1.9 (-6.4, 2.7) -1.3 (-6.8, 4.3) 
Previous night sleep duration Hour -0.03 (-0.7, 0.7) 0.5 (-1.1, 2.0) 
Previous night - Movement and fragmentation  14.6 -4.5 (-17.4, 8.4) -8.4 (-28.4, 11.6) 
Same day sleep (nap) duration Hour -2.5 (-4.1, -1.0) -7.5 (-13.0, -2.0) 
Previous night sleep duration X Nap duration Hour 0.8 (0.1,1.5) 0.8 (0.1, 1.5) 
Depression score 3.8 0.9 (-7.9, 9.6) -1.2 (-12.0, 9.6) 
Mental State  5.8 -9.2 (-21.9, 3.4) -10.0 (-24.5, 4.4) 
Bodily pain last 30 days none -2.0 (-7.0, 3.0) -1.3 (-7.0, 4.4) 
Respiratory symptoms none 5.4 (0.9, 9.9) 5.5 (0.4, 10.6) 
Self reported diabetes none -1.8 (-8.0, 4.3) -1.1 (-7.7, 5.6) 
Fatigue  7.7 1.0 (-17.0, 19.0) -0.3 (-21.4, 21.9) 
 
1 Nighttime sleep duration on the night of the nap. 
2 Fully adjusted mixed model included nighttime sleep (hours from actigraphy), movement and fragmentation index (from nightly actigraphy), age (years), race, 
gender, BMI (kg/m2), depression, mental status, bodily pain in the last 30 days (yes/no), cardiovascular disease at the year 6 visit (yes/no), self-reported 
respiratory symptoms (yes/no), self-reported diabetes (yes/no), times up each night, fatigue score. 
Units for continuous variables approximate 1 standard deviation; for dichotomous variables, the referent group does not have the characteristic.
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Table 4-6 Predictors of average nap duration (hour) in Health ABC sleep study participants who reported a daytime nap (n = 178) 1. 
Variable Unit/Referent Percentage difference in average nap duration per unit (95% CI) (unadjusted) 
Percentage difference in average nap 
duration per unit (95% CI) adjusted for 
multiple variables 1 
Race White -0.7 (-28.3, 30.0) 10.9 (-22.7, 44.5) 
Gender Male -20.8 (-4.0, 4.4) -14.4 (-46.1, 17.4) 
Average nighttime sleep duration Hour -1.6 (-12.8, 9.5) -4.1 (-16.6, 8.4) 
Movement and fragmentation  14.6 
57.1 (-121.7, 235.8) 57.3 (-152.0, 266.5) 
Depression score 3.8 8.3 (-40.8, 57.3) -12.3 (-72.4, 47.8) 
Mental State  5.8 -20.4 (-91.8, 51.1) -22.5 (-106.8, 61.8) 
Bodily pain last 30 days none -30.4 (-58.1, -2.6) -40.5 (-73.1, -8.0) 
Respiratory symptoms none -15.7 (-41.3, 10.0) -8.5 (-37.7, 20.6) 
Self reported diabetes none 40.7 (6.3, 75.1) 39.7 (2.4, 77.1) 
Fatigue  7.7 95.1 (-5.0, 195.4) 140.9 (17.3, 262.2) 
 
1 Full linear regression model included nighttime sleep duration (hours from actigraphy), movement and fragmentation index (from actigraphy), age (years), race, 
gender, BMI (kg/m2), depression, mental status, bodily pain in the last 30 days (yes/no), cardiovascular disease at the year 6 visit (yes/no), self-reported 
respiratory symptoms (yes/no), self-reported diabetes (yes/no), times up each night, fatigue score. Units for continuous variables approximate 1 standard 
deviation; for dichotomous variables, the referent group does not have the characteristics. 
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5.0  GENERAL DISCUSSION 
5.1 SUMMARY OF FINDINGS 
Older adults experience multiple changes throughout all dimensions of sleep. Changes occur in 
sleep quality, duration, continuity, architecture, rhythm, and homeostasis 1-4. These changes 
occur independently and concurrent with medical and/or psycho-social comorbidities 5-8. 
Through the use of self-report data, interviewer administered questionnaires, and wrist 
actigraphy we were able to examine associations between sleep dimensions, daytime function, 
fatigue, and daytime sleep in older adults. 
Specifically, this dissertation investigated the association of disturbed nighttime sleep 
with daytime function, daytime fatigue, and daytime sleep (nap) in two large ongoing population 
studies of community dwelling black and white men and women with an average age ≥80 years. 
Study participants were from the Study of Fractures (SOF) and the Health Aging and Body 
Composition Study (Health ABC).  
In the SOF cohort, actigraphy measured nighttime and daytime sleep in older women was 
associated with poorer daytime function. In the Health ABC cohort, self-reported disturbed 
nighttime sleep was associated with higher fatigue in older men and women. In the Health ABC 
ancillary sleep study, actigraphy measured fragmented sleep was associated with higher odds for 
daytime napping. In addition, both Health ABC studies showed strong associations between 
comorbid health conditions and fatigue and napping.  
The above studies contribute valuable information on sleep duration, sleep continuity, 
daytime sleep, and fatigue in older adults and support an association between nighttime sleep and 
knowledge. The association between poorer nighttime sleep and poorer daytime function was 
consistent with previous research showing poorer nighttime sleep to be associated with poorer 
performance, in these cases primarily based on standardized laboratory tasks 9-14. The association 
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between disturbed nighttime sleep and daytime fatigue supported the study hypothesis, and the 
study proposed a global concept of fatigue to include a component of daytime sleepiness. The 
association between fragmented sleep and daytime napping is consistent with the theory of 
homeostatic sleep Process S 15, 16. Finally, the association of comorbid health conditions as 
important confounders and/or mediators in the relationship between sleep and function, sleep and 
fatigue, and between nighttime and daytime sleep was substantiated and found to be consistent 
with previously reported associations. 
A U shaped distribution was found, in the SOF cohort, for total nighttime sleep and 
measures of physical function with women at both extremes functioning more poorly then 
women who averaged 6-7.5 hours of sleep. In the Health ABC cohort men and women with <7 
or >7 hours of self-reported sleep had higher average fatigue scores. Adjustment for multiple 
confounders explained only a portion of the relationship between total nighttime sleep, physical 
function, and fatigue. These U shaped distributions are similar to patterns reported for the 
association of sleep time and self reports of health problems 4, 17. U shaped sleep distributions 
have also been associated with higher risk of morbidity and mortality 18-22 with individuals 
sleeping 6 to 7 hours per night having the lowest mortality risk 18, 20, 23-26. Short sleep duration 
has been associated with an increased risk of chronic health conditions including diabetes and 
impaired glucose tolerance 19, 27-30, heart disease 24, 31, and hypertension 32. Studies of imposed 
sleep restriction have shown predication toward higher mortality, as well as contributing to risk 
factors for several diseases such as diabetes, impaired glucose tolerance, and hypertension 25, 27, 
33. Long sleep (>9 hours) has been associated with higher risk of diabetes 24, 29, 30 and coronary 
heart disease in women 24. The SOF women with total nighttime sleep between 6–7.5 hours 
appeared to function better and the Health ABC men and women who reported 7 hours of sleep 
had lower fatigue scores. These suggest that regulating total nighttime sleep may play an 
important role in minimizing functional decline. 
Maintenance of sleep, a major complaint of older adults 8, was the sleep parameter most 
strongly associated with poorer daytime function, fatigue, and daytime sleep (nap) in this study. 
This research found poorer daytime function, fatigue, and napping associated with higher levels 
of wake after sleep onset in the SOF women; with self reported waking up during the night in the 
Health ABC cohort; and with movement and fragmentation in the Health ABC sleep cohort. 
These findings were consistent with previous literature. Higher levels of nighttime fragmentation 
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occur with aging 1, 3, 34-36 and are associated with: poorer mood and performance on cognition 
and vigilance tests 12, 37, 38, chronic illness 3, 35, 39-42, higher blood pressure, higher cortisol levels, 
higher lipid levels 33, 41, inflammatory cytokines 43, and can result in daytime sleepiness 44, 45.  
This research extended this knowledge to include physical function, fatigue, and napping. 
To determine fragmentation this research used wrist-actigraph measures of wake after 
sleep onset (SOF) and movement and fragmentation (Health ABC sleep study), and self-reported 
waking up during the night (Health ABC). Factors known to cause nighttime fragmentation, not 
measured by this research, include measures of sleep disordered breathing (or obstructive sleep 
apnea) and periodic leg movements (or restless leg syndrome) 3, 37, 38, 46.   
Sleep disordered breathing, defined by the number of apnea (complete cessation of 
respiration) and hypopnea (partial respirations) episodes per hour of sleep is prevalent in older 
adults 3, 47-50. Based on an apnea-hypopnea index (AHI) ≥10-15 (referent ranges: AHI 5-15 = 
mild; AHI 15-30 = moderate 51), sleep disordered breathing has been estimated to range from 45-
62% in adults 60 years or older 48, 52. Large population studies, using an AHI≥15, in adults 60 
years or older, showed the prevalence of sleep disordered breathing was approximately 20% the 
Sleep Heart Health Study (SHHS) 53; and 32% (women) and 42% (men) in the Cleveland Family 
Study 54. For adults 71-100 years, in the Vitoria-Gasteiz, Spain Cohort, the prevalence was 49% 
was women and 57% for men 55. In San Diego County, CA 56% of the women and 70% of the 
men in adults aged 65-95 years with an AHI≥10 were found to have sleep disordered breathing 
48. The high prevalence of sleep disordered breathing in older adults found in these studies 
suggests that sleep disordered breathing is one potential contributing factor to the sleep 
fragmentation exhibited in the Health ABC sleep study participants. Future studies measuring 
disrupted sleep should also include measurements of sleep disordered breathing.  
Another major cause of fragmented sleep in older adults is periodic limb movement and 
restless leg syndrome which have an average prevalence of 45% and estimated range of 25-58% 
52, 56. Although not measured in this study, the possibility these conditions contributed to sleep 
fragmentation in the Health ABC sleep study participants can not be discounted. Similar to sleep 
disordered breathing, future studies measuring disrupted sleep should also include measurements 
of periodic limb movements and restless leg syndrome. 
This study’s finding that sleep fragmentation was strongly associated with taking a 
daytime nap was not surprising, as sleep fragmentation has been shown to be associated with 
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daytime sleepiness 37, 44, 45, 57. The association between nighttime sleep duration, amount of 
fragmentation, and duration of the next days nap was not significant when examined temporally. 
However, when the data was averaged over the week period, the direction of association between 
the nighttime sleep parameters and daytime nap were in the direction expected (shorter duration 
of nighttime sleep, or higher levels of fragmentation were associated with longer nap duration).  
Potential reasons for the lack of association between nighttime sleep behaviors and 
duration of the next days nap may be associated with the study design. The mixed model analysis 
may have lacked sufficient power; not all naps may have been captured; or the study duration 
may have been too short. Future studies should be performed to address these insufficiencies 
either by increasing sample size, or extending the time the wrist actigraph is worn. Additionally, 
the study did not evaluate periods of daytime immobility, or quiet rest periods, which 
conceptually might play an important role in the overall sleep-wake process. The role of these 
immobile periods in the temporal sleep wake cycle could be evaluated by additional analyses of 
the existing Health ABC sleep study actograms, or as a basis for a future research study.  
The lack of a temporal association may represent a more complex relationship between 
sleep homeostasis and the circadian clock over a longer period of time then accounted for in this 
study. In this case not only would the timing of sleep and wake be an issue, but the course of 
daytime alertness would be accounted for by the interaction of the homeostatic and circadian 
process 58. Future delineation of this association would best be determined in a sleep laboratory 
environment. 
The association of a daytime nap, and/or nap duration, with nap night sleep is still 
uncertain. One laboratory study has reported no effect 9, while another found reductions in nap 
night sleep 59. This study’s data, showing a slight reduction in nap night sleep, is consistent with 
the latter. Future research using longer time intervals and/or more participants would elucidate 
this association. 
The association of self-reported disturbed nighttime sleep with fatigue was confirmed in 
the Health ABC cohort. This dissertation focused on fatigue as a daytime symptom, and potential 
consequence, of poor sleep and poor health after noting the high correlation of daytime 
sleepiness (participant self report of napping or participant response to the question how often do 
you feel excessively sleepy during the day) with fatigue. Fatigue, a multi-dimensional, non-
specific syndrome 60-65 is common in older adults, while daytime sleepiness, which is also 
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common, is the specific behavior denoting the propensity to fall asleep during the day, 66, 67. A 
review of the literature shows the incongruent terminology associated with these concepts. The 
final study results suggested the concept of fatigue should include an aspect of sleepiness and 
supported a picture of global fatigue with fatigue as one conceptualization of multiple daytime 
symptoms. 
In general fatigue has been examined in relationship with specific biological (i.e. cancer, 
rheumatoid arthritis, chronic fatigue syndrome) or psychiatric diseases 60, 63, 64, 68-77 and studies 
have not been able to show causality between fatigue and disease, or disease and fatigue, even 
after controlling for multiple confounders. A biological association between fatigue and 
nighttime sleep behaviors is plausible. In the Health ABC cohort, high levels of fatigue were 
associated with self-reported waking up during the night. Multiple nighttime wakening is 
associated with sleep apnea syndrome. Further, fatigue has been associated with  sleep apnea 62, 
78-82. Although biologically plausible that the disturbed nighttime sleep associated with fatigue, in 
the Health ABC cohort, is the result of sleep apnea, this most likely is only one portion of the 
syndromes’ multi-dimensional aspect. Potentially treatment of sleep apnea syndrome would 
reduce fatigue in these older adults. 
The association between nighttime sleep parameters, daytime sleep, and function with 
medical comorbidities is complex, and was noted in this research. This association involves 
multiple biologic pathways, as well as interaction with genetics and environment. Further, the 
associations not only overlap 83, but most likely are bidirectional where comorbidity can 
potentiate disturbed sleep or sleep complaints, and disturbed sleep can potentiate higher risks for 
comorbidity. For example, chronic health conditions can initiate an immune system response that 
may increase inflammatory cytokines subsequently making people sleepy. Conversely, sleep loss 
as a stressor can trigger activation of the early immune response, such as cytokines, that are also 
involved in host-disease response 27, 84.  
This study found self-report of diabetes associated with higher odds of taking a nap, as 
well as with longer nap duration. The hypothesized pathway between diabetes and disturbed 
sleep is complex, and most likely bidirectional. Untreated diabetes has been postulated as a cause 
of daytime somnolence 85 and has been associated with higher odds for daytime sleepiness 6, 86. 
Evidence also suggests disturbed breathing during sleep, as well as chronic sleep loss, is 
associated with the pathogenesis of altered glucose metabolism 27, 29, 87, 88. Future studies 
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incorporating measurements of sleep and nap with measurements of biomarkers and insulin 
resistance may provide evidence to further explain the specific relationship between sleep, nap, 
and diabetes. 
Self-reported respiratory symptoms were associated with higher fatigue and higher odds 
of taking a nap in the Health ABC cohort, consistent with reports in the literature 8, 52, 89-92. 
Respiratory symptoms such as coughing and wheezing also display a bidirectional association 
with sleep apnea syndrome being associated with both the cause 93, 94 and the effect 93. It has 
been postulated that sleep apnea is a heterogeneous disorder with multiple pathogenic causes 
contributing to upper airway collapse during sleep 95. Future refinement of the relationship 
between fatigue and daytime respiratory events, napping and daytime respiratory events, as well 
as the role of sleep apnea syndrome in this relationship specifically targeted towards older adults 
is needed. 
In general, older adults have more chronic health conditions. Recent studies have shown 
associations of inflammatory cytokines with both disturbed sleep and many disease processes, 
and may prove to be a common link. In addition to the associations discussed in the proceeding 
sections, inflammatory cytokines have been associated with short or long sleep duration, sleep 
apnea 79, 96, 97, fatigue 79, 84, 98, 99, daytime sleepiness 79, and acute and chronic diseases 97, 100.74 
Future research where specific markers of inflammation are collected, simultaneous with 
measurements of sleep and function, would help elucidate this relationship. 
This dissertation research was limited by the cross-sectional design that precluded 
determination of causality. It needs to be recognized that while the cross-sectional investigation 
of the association of sleep and poorer function might tend to infer that poorer function and 
daytime fatigue and sleepiness are results of poor nighttime sleep, the other direction of 
association must be considered and future research supported bi-directionally. 
This research was performed in older adults still residing independently in the 
community; therefore care must be taken to extrapolate these findings to other populations. Sleep 
was measured with self-report, diary, and actigraphy. Therefore, measurements only obtainable 
through PSG, such as EEG, EMG, ECG, and respiratory monitors, as well as measurements of 
periodic leg movement, or restless leg syndrome, were unobtainable.  
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5.2 PUBLIC HEALTH SIGNIFICANCE 
Disturbed sleep and daytime sleepiness are common complaints resulting in daytime napping, 
reduced performance, accidents, medical comorbidities, and poorer quality of life 101, 102. 
Prevalence rates of poor sleep in older adults range from 13–57% 7, 91, 92, 103, 104. Disturbed sleep 
and its associated sequelae represent major public health problems and have a significant impact 
on older adults.  
The financial burden related to poor sleep is considerable with estimated direct and 
indirect costs ranging from approximately $13.9 billion to over $30 billion dollars (1995 dollars) 
105-108 to tens of billions annually in 2005 109. Additional associated costs range from $50 billion 
110 to as high as $100 billion annually when lost productivity, medical expenses, sick leave, 
property, and environmental damages are included 101, 108. 
This dissertation research has substantiated the relationship of poorer daytime function 
and fatigue with inefficient sleep duration and nighttime sleep fragmentation. This research has 
highlighted the association of disturbed sleep with medical comorbidity; especially diabetes, 
respiratory symptoms, and pain with daytime napping. This additional knowledge may help with 
future identification of the causal pathway between disturbed sleep and daytime function. This in 
turn may promote additional research in the area and open the field towards potential therapeutic 
or targeted interventions. 
As the population ages, recognizing the association between sleep and subsequent 
daytime sequelae may help to reduce subsequent comorbidities and improve the quality of life in 
community-dwelling older individuals. Overall, these findings provide epidemiological evidence 
for an association between poor nighttime sleep and daytime napping, fatigue, and poorer 
daytime function in older adults. 
5.3 FUTURE RESEARCH 
At this time there is minimal empirical data to guide older adults, their caregivers, and physicians 
on how to optimize nighttime sleep, minimize daytime fatigue, and to suggest whether or not 
napping should be avoided or recommended. While the association of comorbid medical 
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conditions with disturbed sleep has been shown, there is minimal evidence validating the role of 
disease management in improving nighttime sleep, daytime fatigue, daytime napping, and 
subsequent morbidity and mortality. Future research is needed to confirm these associations and 
clarify associated risk factors. 
Additional longitudinal cohort studies are needed to confirm this study’s findings that 
disturbed nighttime sleep was associated with poorer daytime function, fatigue, and napping in 
other cohorts of older adults; and to confirm the associated risk factors. As the associations found 
in this study are based on cross-sectional data, further longitudinal analyses may elucidate these 
associations. Further, clarification of associated risk factors might identify potential treatment 
options.  
Sleep fragmentation was found to be associated with poorer daytime function in all three 
dissertation papers. Interventions to reduce nighttime fragmentation and subsequently improve 
nighttime sleep, and improve daytime function are needed specifically targeted at older adults. 
Potential interventions could include positive airway pressure for treatment of sleep apnea, or 
sleep disordered breathing; medications for periodic limb movements; improvement of sleep 
hygiene; or treatment of the underlying disease processes.  
The associations found between self-reported comorbid diseases, particularly self-
reported diabetes and self-reported respiratory disease and daytime sleep indicates the need for 
future research to confirm the disease status in this population, as well as in other populations, to 
validate the disease-nap association. 
A cross-sectional study could be performed in the Health ABC sleep study cohort to 
elucidate the association of poor nighttime sleep, daytime sleep and fatigue with self-reported 
respiratory conditions. Examination of existing pulmonary function test data can be assessed to 
determine if the self-reported respiratory conditions are associated with obstructive or restrictive 
pulmonary disease. Additional analyses could subsequently address the association between 
obstructive, or restrictive, respiratory disease with fragmented nighttime, daytime sleep and 
fatigue. If associations are found future research could evaluate interventions targeted at the 
cause of the reduced function as a potential avenue to improve nighttime sleep. 
Another cross-sectional study could be performed to corroborate the association between 
actually reporting a nap during the day, nap duration, and diabetes. Research where serum 
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samples are collected and medication use is verified to confirm disease status, simultaneous with 
objective measures of sleep would help confirm and refine this association.  
Future research on the association of comorbid health conditions with nighttime sleep 
behaviors, fatigue, and daytime napping is warranted. The role of disease management in 
improving nighttime sleep, fatigue, and daytime sleep is not clear. A case-control study could be 
performed to test the hypothesis that tight disease control will improve night-time sleep, 
minimize daytime fatigue and/or napping is needed  This study would provide information on 
whether or not tight disease control would facilitate better nighttime sleep and daytime function. 
Comorbidities, amenable to control that have been associated with sleep, napping, and fatigue 
such as diabetes, cardio-pulmonary diseases, hypertension, and pain could be addressed. The 
research would establish guidelines as to what level of disease management is optimal. 
Methods exist to perform studies pertaining to nighttime sleep over an extended period of 
time in community based settings using wrist actigraphy and/or PSG. However, improvement in 
methods to measure both fatigue and daytime sleep in community based settings is needed before 
the impact of these parameters, in older adults, can be fully determined. Fatigue scales validated 
in other populations exist and would be suitable to measure fatigue in older adults. However, 
these should be formally tested and validated in the older adult population. Research to 
refinement and validate wrist actigraphy algorithms to quantify daytime sleep, versus periods of 
inactivity, would provide more accurate estimates of the impact of daytime sleep independent of 
inactivity in older adults. 
5.4 CONCLUSION 
Sleep behavior and daytime function change with aging. Poor nighttime sleep has been 
associated with poorer daytime performance, fatigue, and increased daytime napping in older 
adults. A cross-sectional association of poor nighttime sleep, measured with wrist actigraphy, 
and poorer gait speed, time to complete five chair stands, grip strength and IADL impairment 
was found. Fragmented nighttime sleep, measured by self report and actigraphy, was found to be 
associated with higher odds for napping, poorer daytime function, and a higher fatigue score.  
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The role of comorbid health conditions, in particular self-reported diabetes and respiratory 
symptoms, with daytime fatigue and napping was observed. 
Factors associated with nighttime fragmentation in older adults have been identified in 
other studies, and methods to reduce this fragmentation need to be tested specifically in older 
adults. Future studies are needed to confirm the longitudinal association between poor sleep 
behaviors, fatigue and daytime function (or disability); to determine the association of poor sleep 
behaviors and morbidity and mortality over time; to refine the association of comorbid disease 
with nighttime and daytime sleep; and to better validate methods to assess daytime napping and 
fatigue specifically in older adults. Mechanisms to improve sleep behaviors specifically targeted 
to older adults need to be identified, evaluated by clinical trial, and integrated into practice. Once 
these associations have been established the true public health impact can be determined. 
Intuitively, improvement in sleep behaviors may help improve performance, reduce daytime 
napping and reduce daytime fatigue. 
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SUMMARY OF STUDIES ON SLEEP, NAPPING, AND ACTIGRAPHY 
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Table A5-1 Summary of epidemiologic studies evaluating sleep in older adults 
Author – Study Population Methods Risk Results Comments 
Ohayon MM 2005 
 
190 
n = 25,580 
 
Location: France, 
United Kingdom, 
Germany, Italy, 
Portugal, Spain, 
Finland. 
Telephone Interview- 
Sleep EVAL system 
(computerized 
questionnaire). 
 
Non-restorative sleep 
(NRS) analyzed in 
relationship to socio-
demographic, 
environmental factors, life 
habits, health, sleep-wake 
schedule, psychological 
factors. 
Prevalence of non restorative 
sleep was higher 
in women than in men 
(12.5% vs. 9.0%; P=0.001), 
and decreased with age. 
Prevalence of NRS was 
10.8% (95% confidence 
interval, 10.4%-11.2%) 
in the sample. 
The United Kingdom 
(16.1%) 
and Germany (15.5%) 
had the highest 
prevalence of NRS 
and Spain (2.4%), the 
lowest. 
 
 
Foley D et al 1995 
 
EPESE 
13 
 
 
n = 9,282  
 
Locations: 
East Boston, MA 
New Haven, CT, and 
Iowa 
 
Average age: 73.3 – 
74.5. Age range did 
not differ 
significantly by site. 
 
Females 61% 
 
Blacks only included 
at New Haven, (% of 
population not given). 
Interview (in person): 
Sleep questions- how 
often experience (no 
reference period of time): 
 -falling asleep 
 -wakening up in the 
night,      -wakening up to 
early, 
 - if they got so sleepy 
during the day or evening 
that they have to take a 
nap,  
- if they felt rested when 
they wake up in the 
morning.  
A sleep complaint score 
representing the sum for 
the frequency of the 
responses was used. 
 
Three measures to reflect 
the dichotomies for sleep 
deprived syndromes: 
 - difficulty initiating and 
Age: 
- average sleep complaint 
score generally higher with 
age 
-insomnia increased with age 
in Iowa only. 
 
Female sex: 
-Average sleep complaint 
score significantly higher in 
women. 
-Insomnia significantly 
higher OR 1.36(1.23-1.50) 
- Less likely to nap more 
during the day. 
 
African Americans; New 
Haven only. Significantly 
lower complaint scores on 
average (18%) Percent for 
whites only was not given. 
 
BMI no association 
 
Difficulty initiating & 
maintaining sleep was 
the most prevalent sleep 
deprived syndrome (35 
– 40% of cohort). 
 
Insomnia 2nd most 
prevalent complaint (23-
34%). 
 
Awakening not rested 
reported by 15% in East 
Boston & New Haven, 
but only 7% in Iowa. 
 
Prevalence of: 
DIS 19% 
DMS 29% 
EMA 18% 
INS 28% 
Not feeling rested after 
am awakening 13% 
No complaints 12% 
- Poorer self-rated 
57% reported at least 1 
chronic complaint 
occurring most of the 
time; 
 
Longitudinal analyses of 
sleep complaints 
associated with 3 yr 
mortality found napping 
was associated with a 
marginal increase in risk 
OR 1.17(1.03-1.33) and 
nighttime awakening.  
A marginal decrease in 
risk OR 
0.80(0.7000.91). (no 
information was given 
on nap behavior) 
 
No association between 
insomnia and mortality 
or nursing home 
admission after 
adjustment for age, sex 
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maintaining sleep 
(DIMS), 
 -insomnia 
 - awakening not rested.  
 
Participants were also 
asked questions regarding 
self perceived health 
status (SPHS), CES-D 
scale, SPMSQ, ADLs, 
respiratory symptoms, 
chronic diseases, BMI, 
smoking, alcohol, and 
medications.  
 
 
Poorer self-rated health OR 
1.20(1.08-1.34), elevated 
depressive symptomatology 
OR 2.53(2.25-2.85), and 
increasing number of 
physical disabilities OR 
1.16(1.05-1.29) (note 
reported for 2 or more 
conditions), respiratory 
symptoms, medication use 
were associated with higher 
frequency of overall 
complaints represented by 
sleep summary score. 
OR also increased but not 
significant  with any ADL 
limitation 1.17 (1.00 – 1.38) 
and ambulatory limitation 
1.12(0.99-1.27) 
Note OR’s here are for those 
with reported insomnia (29% 
of population). 
 
Use of anxiolytics and 
barbiturates were associated 
with sleep complaints. OR 
1.80(1.51-2.15) 
health, elevated 
depressive 
symptomatology, 
increasing number of 
physical disabilities, 
respiratory symptoms 
and non-prescription 
medications associated 
with a higher frequency 
of overall complaints 
(summary sleep score 
range 57-60). 
& disability. 
 
Data suggested that 
considerable proportion 
of sleep complaints may 
be associated with 
chronic disease and 
other health problems 
that are more prevalent 
among older persons. 
Jean-Louis G, 
200022 
 
 
 
 
 
 
 
San Diego  
n = 273 
144 W 
129 M 
203 Non-Hispanic 
whites 
70 Minorities 
 
mean age 51 ± 7 
Interview: 
-subjective sleep duration 
-difficulty falling asleep 
@ night  
-sleep satisfaction (1-5 
scale) 
-health status (1-5 scale) 
-caffeine, alcohol & 
smoking 
-Quality of Well Being 
Scale 
-CES-D  
 
18%  of the variance in 
QWB explained by: 
-greater sleep satisfaction 
-younger age, 
-less obesity, 
-non Hispanic White 
-greater illumination 
 
80% satisfied with their 
sleep 
 
Reported sleep 
satisfaction was 
correlated with reported 
habitual sleep time (r=-
0.28, p<0.001). 
 
Neither subjective or 
actigraphic sleep 
duration were associated 
with QWB  
QWB did not have a U-
shaped relationship with 
sleep duration. 
 
No evidence that greater 
sleep duration was 
associated with greater 
health related QOL. 
Table A5-1 cont. 
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Table A5-1 cont. 
 
Actigraphy  (Actillume) 
for 3 days at home to 
measure: 
-nocturnal sleep duration, 
sleep onset latency, 
-sleep efficiency 
 
Self-reported & 
actigraphic sleep 
durations moderately 
correlated (r=0.35, 
p<0.001). 
Whitney CW et al 
1998 
 
CHS study  
1993- 1994 exam 
 
109 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5201 recruited from 
1989-1990, with 687 
additional non-white 
from 1993-1994. 
 
Forsyth County, NC 
Sacramento Co, CA, 
Washington Co, MD 
Allegheny Co, PA 
 
age range 65 – 99, 
mean age 76 yrs. 
 
White 4578 
African American 
3808 
 
59% Female 
 
 
Daytime sleepiness  by 
ESS; 
Other sleep questions 
included: 
-Do you often wake up at 
night? 
  -if so what are the 
reasons 
-Do you often feely 
groggy and unrefreshed 
for more than an hr after 
waking up in the AM? 
-Are you usually sleepy in 
the daytime/ 
 
General health question. 
Brain MRI; 
Cognitive function tests; 
Questionnaires of 
cardiopulmonary; 
Depressive symptoms 
(CES-D); social support; 
ADL’s; Physical activity; 
Medications 
African American men: 
 - less likely to report DMS 
(22% vs. 27% white men, 
31%  black female, 35% 
white female) 
- significantly higher mean 
ESS scores (7.13 vs. 6.59, 
4.50, 3.59) 
 
Self reported general health 
status strongly associated 
with ESS scores. Older 
women with poor health 
7.48 compared with 4.06 for 
excellent health. 
 
Men and non-white 
participants had higher ESS 
scores than women.  
-men in excellent health had 
a mean ESS score of 6.29 ± 
4.06 compared to 4.06 ± 
3.21 in women. Men in poor 
health men had a score of 
7.61 ± 4.92 vs. 7.48 ± 5.63 
in women. 
 
Higher depression ( scores > 
14)  in men & women had 
higher mean ESS scores  
 
Obesity indicators –BMI, 
waist circumference & waist 
to hip ratio positively 
20% usually sleepy in 
the daytime 
 
Average ESS score was 
5.85±4 (range 0-24). 
 
In gender specific 
models independently 
assoc with higher ESS: 
non-white, depression, 
loud snoring, awakening 
with dyspnea, DIMS, 
CHS meds, non-use of 
sleeping pills, sedentary 
life-style, limitation of 
ADL's. 
 
No association with 
EDS in models; age, 
education, beer or wine 
to aid sleep, tricyclic, 
benzodiazepines, 
asthma, angina, MI, 
CHF, FVC, social 
support, cognitive 
function, MRI atrophy 
or white matter 
abnormality. 
Mean levels of EDS in 
this study were similar 
to those in younger 
persons. 
 
ESS higher in men & 
non-whites. 
 
Higher rate of EDS with 
OSA, nocturnal sleep 
disruption, depression, 
diminished physical 
activity, heart disease, 
and age in both bivariate 
& multiple regression. 
 
Nocturnal awakenings 
to use the bathroom and 
from leg cramps were 
predictive of EDS. 
 
ESS only slightly 
associated with 
cognitive impairment. 
 
Inverse relationship 
with activity (Kcals) 
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Table A5-1 cont. associated in univariate 
analysis, only hip 
circumference was an 
independent factor in 
multiple regression. 
 
No finding with pulmonary 
function (however 
significant associated with 
digitalis & diuretics). 
Redline S et al 
2004 
 
SHHS (PSG sub 
study) 
 
191 
 
 
n=2,685 of 6,443 
(total SHHS) 
 
age 61.9 ± 10.9 (37-
92) 
49.6% Female 
77.8% White 
 
excluded individuals 
with exposures or 
conditions likely to 
effect sleep 
architecture other 
than SDB 
 
 
In home overnight  PSG: 
percentage time each 
sleep stage, arousal index 
and sleep efficiency. 
 
Sleep habits questionnaire 
for perceived sleep 
disturbances & quality. 
 
Independent variables age, 
sex, ethnicity,, 
comorbidity status, RDI 
 
Men lighter sleep than 
women  (Stages 1 & 2) 
(p<.001) 
 
AA & American Indians 
lighter sleep compared to 
other ethnic groups. 
 
Age: increasing age 
associated with impaired 
sleep in men, 
less consistent with women 
% stage 1 & %stage2 
significantly higher in 61+ 
yrs compared with 54 yr or 
younger. 
% REM significantly lower 
in those ≥ 61 
Sleep efficiency decreased 
significantly with age  
 
Women: on average, 106% 
more slow wave sleep 
Obesity – little effect on 
sleep 
Current smokers- lighter 
sleep 
Females tended to spend 
on average 23% less 
percentage stage1, about 
12% less percentage 
stage 2, about 5% more 
percentage REM and 
106% more percentage 
stage 3-4. Women also 
spent a longer period 
asleep than men 
(6.05±1.00 vs. 
5.75±1.00 hrs, p<.001) 
Age was negatively and 
linearly associated with 
all measures of sleep 
architecture other than 
percentage stage 1. 
RDI > 45% found in 
45% 
10% CVD & lung 
disease 
34% HTN 
 
Finding of objective 
measures of better sleep 
quality in women 
contrast with previous 
studies that have shown 
greater perceived sleep 
difficulties in women. 
Association of sleep 
architecture with 
chronic disease after 
adjustment for age, 
SDB, & sex was only 
significant with a 
history of HTN (relative 
to SLE) & prior history 
of stroke (relative to 
stage1). These analyses 
however were in 
relatively healthy 
individuals without 
frequent nocturnal 
awakenings. 
Quan, SF et al, 
2005 
n=4,467 Sleep questionnaire at 
baseline then 1-4 yrs later: 
  Most important factors 
related to development 
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TableA5-1 cont. 
 
CHS 
24 
 
 
   - EDS, snoring, trouble 
falling asleep 
 
 
of sleep disturbance is 
poorer mental health, 
although somatic 
disease contributes 
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Table A.5-2  Summary of epidemiological studies evaluating sleep duration and mortality 
Author - Study Number Age  Method Results Comments 
Hall et al. 2005 
 
Health ABC  
3075 (52% 
F) 
42% AA 
 
68 - 80 Self report at 5th 
annual study visit.  
Crude mortality at yr 
5 confirmed by death 
certificates & medical 
history. 
Women more likely to report < 6 hrs sleep. 
Blacks more likely to report both <6 and > 8 
hrs  
Mortality was related to sleep duration, 
highest rates in those with < 6 hrs and > 8hrs. 
HR adjusted for demographics, health & 
smoking: <6hr 1.56 (1.11-2.18) and >8 hr 1.93 
(1.28 – 2.79) 
Unpublished data. 
Mortality was higher 
in both lower & higher 
duration. Associations 
partly explained by 
poorer health status 
and elevated 
inflammatory markers. 
Youngstedt SD 2004 
 
Long sleep and 
mortality 
 
11 
 
 
various various Review article of 17 
epidemiological 
studies. 
Sleep above 8 hr is associated with higher 
mortality. 
U shaped association of sleep duration with 
mortality was found in all studies comparing 
several sleep durations. 
In large studies comparisons of men & women 
showed similar sleep-associated risks.  
Control of covariate risk factors had only 
modest effects in some studies. 
 
Unknown the extent 
that reported sleep 
durations represent 
physiologic sleep 
duration of just TIB. 
Grandner MA et al 
2004 
 
Self reported sleep 
complaints with long 
& short sleep 
28 
 
 
1004 (49.8% 
M) 
82% White 
44.28±16.46 
(range 18-86) 
Self-reported sleep 
complaints (latency, 
nighttime 
awakenings, morning 
awakenings, non 
restorative sleep, and 
DS compared with 
reported hrs of sleep. 
From NSF 2001 
Sleep in America 
Poll. 
Overall TNST was 6.99 ± 1.48 hrs. TNST was 
significantly related to all sleep complaints. 
U shaped distribution for TNST and sleep 
duration and note how it parallels the U 
shaped distribution associated with TNST and 
mortality  
TNST showed 8 hr sleepers reported less 
frequent symptoms than long sleepers or 7 hr 
sleepers. Those who slept >8 hrs reported 
significantly more sleep complaints. 
Did not present 
analysis for sleepers < 
7 hrs. 
Data collected by 
telephone interview 
therefore reliability 
and validity is limited. 
Kripke DF et al. 1979 
 
1959-1960 American 
Cancer Society 
volunteers  
 
26 
 
366,493 M 
& 456,572 F 
range 30 - 
>9o 
Questionnaire. 
Sleep questions: how 
many hrs of sleep do 
you usually get a 
night? Check yes or 
no for insomnia. How 
often do you use 
sleeping pills. 
Most common usual sleep duration was 8 – 
8.9 hrs in men & women. Insomnia often 
reported usually sleeping about 1 hr less than 
those with none. Women reported insomnia 
about 2X more than men. 
Both more likely to have died in the 6 yr 
follow-up if they reported usually sleeping 
either more or less than 7 – 7.9 hrs. U shaped 
Questionnaire reported 
extremes of usual 
sleep duration, < 5 or 
≥ 10 hrs were almost 
as strong predictors of 
6 yr mortality as 
reports of having ever 
had diabetes, heart 
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Author - Study Number Age  Method Results Comments 
 
Mortalities traced for 
6 yrs. 
Referent group 7 – 
7.9 yrs 
relationship of sleep duration to mortality 
highly significant (p <.005) 
Men reporting < 4 hrs were 2.80 times as 
likely to die & Women 1.48 times. 
disease, stroke or 
HTN in both sexes 
and all age groups. 
No referent sleep time. 
Kripke  DF et al. 2002 
 
Mortality associated 
with sleep duration 
and insomnia. 
1982 CPSII 
 
27 
 
 
1.1 million W: 57 ± 11 
yrs; 
M: 58 ± 10 
yrs 
Questionnaire: On 
average, how many 
hours do you sleep 
each night, and how 
many times a month 
do you have 
insomnia.  
Survival or death rate 
(from death 
certificate) 6 yrs later. 
Modal sleep duration 8 hrs. Almost 50% 
reported ≥ 7.5 hrs. 
After adjustment for 32 covariates best 
survival was in those reporting usual sleep 
duration of 7 hrs. In W HR > 7 ranged from 
1.07 – 1.33(3 hrs) and in men 1.08 to 1.19. For 
> 7 hrs the HR in W ranged 1.13 – 1.41 
(≥10hrs) and in men from 1.12 – 1.34. 
Insomnia was not well defined. Was not 
assisted with any excess mortality. 
 Comparison of the 32 covariate models with 
simplified models & CPSI tabulations showed 
most mortality risk associated with short sleep 
could be explained by comorbidities. 
 
Population surveyed 
was limited to ACS 
volunteers and 
associated.  
Only one sleep 
question was asked. 
Patel SR et al 2004 
 
Sleep duration and 
mortality risk. (Nurses 
Health Study) 
 
29 
 
 
82,969  W 
answered 
sleep 
question. 
average 53±7 
(approximated 
from data 
given) 
Questionnaire at 
baseline in 
1986Indicate total 
hours of actual sleep 
in a 24 hr period. . 
Mortality ascertained 
over 14 yrs (1986-
2000), 
Referent group 7 hrs. 
Women reporting long and short sleep 
durations tended to be older & heavier and to 
have more illnesses (for 7 hrs age 52.8±7.2 vs. 
53.8±7.4 for ≥9 hrs). 
History of night shifts more common in those 
sleeping ≤ 5hrs. 
Significant increase in mortality risk for both 
short and long sleepers. For ≤ 5hrs RR 
1.41(1.25-1.28), in 9hrs 1.72 (1.55-1.91). 
Adjustment for HTN and diabetes, and shift-
work history in short sleepers resulted in 
reduction in excess mortality risk to a level not 
significantly different than 7 hrs. Adjustment 
had little effect on over 7 hrs. 
Lowest sleep category 
was ≤ 5. 
Physical activity, 
depression and alcohol 
were the largest 
confounders of short 
sleep, and physical 
activity was the 
primary confounder of 
long. These variables 
were not defined 
further. 
Table A5-2 cont. 
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Table A.5-3 Summary of studies on napping in the community 
Author - Study Number Age  Intervention Results Comments 
Tamaki et al. 1999 
 
Effects of daytime 
naps (Japanese) 
 
12 
 
6 
 (Sex not 
given) 
72.2 (range 
66 – 78) 
Nap and rest condition 
with 1 wk between. 
Nap – went to bed 13:00 
and awakened 30 min from 
onset of stage 1 sleep. 
Rest condition – watched 
videotape for 30 min.  
 
Reaction time shorter in the nap after 14:00h & 
percentage correct on visual detection task was 
higher, & subjective sleepiness was lower 
(however no data provided) 
 
EEG α band activity higher after rest more than 
nap showing arousal level improved with nap 
(relative amplitude 2uV vs. .5uV)  
DBP decreased from 80-70 after nap vs. 78 – 80 
after rest (p<0.05). 
Small study. 
Minimal data presented. 
Participants were habitual 
nappers. 
Tamaki et al. 2000 
 
Effects of  <30 min 
afternoon nap on 
mood, 
performance, & 
EEG 
(Japanese) 
13 
 
10 (5M & 
5F) 
73.0 ± 3.62 Nap and rest condition 
with 1 wk between. 
Nap – went to bed 13:00 
and awakened 30 min from 
onset of stage 1 sleep. 
Rest condition – watched 
videotape for 45 min. 
 
Mood after waking from nap (average 5.2/7) and 
at 3 min after rising (6.3/7) 
Percentage correct on  the visual detection test 
showed the percentage correct significantly 
decreased at 14:40h in the no-nap (99.4%) vs. the 
nap(99.8%) in the nap (p<.05). 
Amplitudes of theta, alpha 1, alpha2 & alpha 3 
band activities on EEG were lower or maintained 
after the nap, and higher without the nap. 
Nap time was set at 13:00h 
during intervention. 
Authors also looked at one-
week actigraph activity in 
normal life. Frequency of 
daytime naps in 1 week 
averaged 4.6 ± 0.33. Duration 
of nap episode was 37.8± 5.21 
min. No. of daytime nap 
episodes/day was 1.4 ± 0.09. 
Of 115 daytime naps recorded, 
24% occurred from 13:00 – 
13:30 h and 84% between 
12:00 & 15:00 h   
Campbell et al. 
2005 
 
Effects of nap on 
nighttime sleep 
and waking 
function. 
 
(New York) 
14 
 
32 (16M & 
16F) 
68.5 ± 8.1 
range:55 -
85 
Two lab sessions, each 3 
nights & following days, 
separated by 1 wk. Nap or 
sedentary between 2 & 4 
pm. 
 
Average sleep time during the 2-h nap 81 ± 25.9 
min (range 11.5 – 108.5 min). 
Sleep onset latency after the nap took average of 
6.3 min longer than under sedentary conditions. 
Performance measured by the Wilkinson four-
choice reaction and the Stroop task showed 
significant improvement. 
Napping also associated with significant 
improvement on next-day performance for 
accuracy on the logical reasoning task, and 
throughput on the 2 letter reasoning test (p<.03) 
In 24 hr period containing the 
nap compared to 24 hr 
sedentary, subject’s average 
more than an hr more total 
sleep (7.4 vs. 6.2 hr). Primarily 
in the form of REM & Stage 2 
sleep.  
Results presented in bar graph 
showing percentage difference 
in performance from the 
sedentary to the nap condition, 
   
 108
Table A5-3 cont. No difference in sex. (no tables). 
Performance changes were 
only correlated with nap 
variables not nighttime sleep 
variables. 
Hays JC et al 1996 
 
Risk of napping: 
Excessive DS & 
mortality  
 
(EPESE – NC) 
15 
 
3962(1381M 
& 2581F) 
65 – 101 Four year prospective 
cohort study. 
Questionnaire – sleep 
related variables self-
report. 
Point prevalence of EDS = 25.2%. Frequent 
daytime nappers were more likely to report 
nighttime sleep complaints, to be male, to report 
more depressive symptoms, more limited physical 
activity, more functional impairment, & to be 
overweight. 
 
23.9% of frequent nappers died compared with 
15.4% of infrequent, The 4-yr mortality rate was 
accelerated 1.73 times in those who napped most 
of the time and made 2 or more errors on 
cognitive status examination, 
First large scale population 
based controlled study to look 
at mortality risk associated 
with napping. 
 
Excessive napping appeared to 
be associated primarily with 
impaired sleep hygiene which 
the authors note as the 
polyphasic patterns of 
fragmented nighttime sleep. 
Frisoni GB et al 
1996 
Napping - 
association with 
night sleep and 
psychological 
status 
 
(Italy) 
16 
 
n = 223  
W(67.7%) 
M 80.3(4.2)  
W 81.5(4.6) 
Questionnaire: 
- How often in the past 
week did you take nap 
because you felt sleepy? 
- Sleep measures: TFS, 
WUDN, EMW, NFRAM 
Napping had bimodal distribution: no nap 76.2%, 
≥ 1day/week 23.8%. 
Unadjusted: 
- EMA OR 1.2 (0.03 – 0.37, p=0.18) 
- NFRAM  OR 1.2 (0.00 – 0.33, p=0.05) 
Adjusted: 
- EMA OR 1.1 (-1.63-1.85, p=0.215) 
- NFRAM  OR 1.2 (0.00 – 0.353, p=0.05) 
 
Obsessive-compulsive 
behavior’s psychological 
symptom most closely 
associated with napping  OR 
1.95 (0.08 – 1.26, p=0.03) 
 
Asplund R, 1996 
 
DS and napping in 
relation to somatic 
health. 
(Sweden) 
17 
 
 
n = 6143  
M(39.5%) 
M 73(6) 
W(72.6(6.7) 
Questionnaire: 
- I’m often sleepy in the 
daytime 
- I usually sleep for a while 
in the daytime 
- I’m often unable to fall 
asleep despite sleepiness in 
the day 
 
- Cardiovascular diseases, snoring, pain, diabetes 
was associated with higher DS 
- WUDN were more sleepy during the day M 
2.7(2.2-3.4), W 2.7(2.3-3.2); TFS M 2.4(1.8-3.1), 
W 2.3(1.9 – 2.8) 
- Age-related increase in nap seen in M & W with 
a good night’s sleep 
Nap information was 
extrapolated from DS 
information. 
- 32%M and 23.2%W sleepy 
during day 
- Odds of DS increased in 
relation to number of nocturnal 
voiding episodes. 
- Odd of DS increased with 
impaired sensory or 
neurological function. 
 
 
 
n = 442 
(Gender not 
given) 
70 yrs Questionnaire: 
- Do you nap every day? 
- Duration of your nap? 
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Table A.5-4 Summary of studies of on napping and actigraphy in older adults 
Author - Study Number Age  Method Results Comments 
Usui A et al. 2003 38 
 
 
Naps that are not 
recognized as naps. 
 
 
14 (no 
gender 
given) 
mean 73.8 
yrs 
Wrist actigraph 
(Motionlogger Actigraph) 
for 4 – 7 days. 
Sleep-log. 
Fell asleep 21:04 and woke 05:51. The 1hr 
agreement ratios for actigraph & sleep log dropped 
in the periods 04:00-07:00, 13:00-16:00 and 19:00-
22:00. False sleep ratios were high during 04:00-
07:00 and false wake ratios were high during 13:00-
16:00 and 19:00-22:00.  
False wake ratios imply 
that older often have naps 
not subjectively 
recognized as naps. 
Study also had 25 controls 
(27.6) however actigraph-
log comparisons not 
given. 
Yoon IY et al 200464 
 
 
Naps & circadian 
rhythms in WHI 
 
 
 
436  
 
67.8 ±  7.9  
(range 50 -
81_ 
Wrist actigraph 
(Actillume) for 1 week. 
Daily sleep logs. 
 
. 
 
All day nap duration significantly increased in 70-
81 yr olds compared to 50-59 yrs or 60-69 yrs old 
(p<.01). Evening nap duration tended to increase 
with age being higher in the 70-81 yr group 
compared with the other 2 age groups (p=.064). 
Averaged all-day and evening nap durations were 
31.3 & 7.75 min. A significant inverse correlation 
occurred between evening nap duration and wake-
up time, but not with all day nap or non-evening. 
Nap duration was correlated with wake-up time. 
Study designed to look at 
depressed (n=30) vs. non-
depressed women 
(n=222). 
Study also looked at 
aMT6s acropahse. 
Yoon IY et al 200362 
 
 
Age-related differences 
in napping & nocturnal 
sleep 
 
 
60 older 
(38W & 
22M); 73 
young 
(47W & 
26M) 
66.2 ± 4.9 
 
23.5 ± 3.8 
 
-generally 
healthy 
Wrist actigraph 
(Actillume) for 1 week. 
Daily sleep logs.  
Naps were counted as ‘any 
short sleep episode’ out of 
bed without criteria on the 
duration 
Used 10h after wake-up & 
10 h before bedtime 
Afternoon naps defined as 
naps from 4 h after wake-
up to 6 h before sleep. 
Evening naps defined as 
out of bed sleep from 2 hr 
to just before bedtime 
Bed & wake-up times, sleep onset & offset times 
significantly earlier in older age group (p<0.001) 
76% of older and 61.6% of younger had at least 1 
nap (p=0.064). Nap time 23.3 and 17.3 min/day 
respectively. Younger group exhibited more 
napping during the 10 h after wake-up (p<0.01) 
(Greater in the afternoon) Older had significant 
increase 2 h before bedtime.  
While no difference in 
duration of naps, older 
adults napped more in the 
evening. Older adults with 
evening naps had earlier 
nocturnal wake-up times 
and decreased nocturnal 
sleep duration compared 
with those without. 
Evans et al 199412 
 
 
24 hr sleep wake patterns 
14 (13F 
& 1M) 
81.2 ± 5.9 
(range 71 – 
91) 
Wrist actigraph 
(Actillume) for 48 hrs.  
Activity diaries every 15 
min. 
Naps were longest in the afternoon, 42.9% occurred 
between 12 & 6 pm. 37.6% occurred between 6pm 
and midnight, and 19.5% from 6am to 12 noon. 
Subjects reported taking an average of 1.79 
Data based on 48 hrs 
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Author - Study Number Age  Method Results Comments 
Table A5-4 cont. 
 
 
naps/day compared with an average of 5.2 naps 
recorded by actigraphy.        No relationship was 
found between ages and napping. 
Buysse DJ et al 1992237 
 
 
Napping & 24 h 
sleep/wake patterns 
 
 
 
45 older 
(21M & 
24 F); 33 
(20M & 
13F) 
young 
83.1 ± 2.1 
 
24.9 ± 3.0 
2 – week sleep/wake diary 
2 nights PSG  
Older reported > mean number of naps over 2 
weeks (3.4 ± 1.3 vs. 1.1 ± 1.4 p=0.004). 35.5% of 
older and 54.4% of the young reported no naps. 
Average time of naps was not significantly different 
between groups.   
Trend for women to be more frequent nappers than 
men X2=2.81, p=0.09.  
More frequent nappers had lower mean scores than 
infrequent nappers on the Hamilton Rating Scale 
for Depression and the Folstein Mini mental State, 
however not clinically significant.                
PSG reports older had 
shorter sleep time, more 
awakenings, more time 
awake during the night, 
less REM and slow wave 
sleep. Sleep latency did 
not differ. These were 
consistent with self report. 
Ceolim NF et al. 2000192 
 
 
Sleep/wake cycle & 
activity 
 
 
 
 
23 70.17 ±  
3.55 (range 
65 – 76) 
Wrist actigraph for 2 
weeks. 
Sleep logs and activity 
diaries. 
Long exercisers reported slightly higher number of 
naps than SE group (0.49±0.51/day and 
0.39±0.50/day), with the mean duration of naps in 
LE group being slightly higher (46±42 median 
30min, and 44±42, median 30).  
 
Authors note that the 
association between a 
longer duration of 
physical exercise and the 
semi circadian sleep wake 
cycle imply a possible 
beneficial role for naps as 
part of a healthy lifestyle. 
Monk TH et al 200141 
 
90 min afternoon nap on 
nocturnal sleep, 
circadian rhythms, 
evening alertness & 
performance levels 
 
9 (4M & 
5F) 
mean 78.6 
range 74 - 
87 
PSG, wrist actigraphy, 
sleep diary. 
Two studies with nap & no 
nap conditions for 14 home 
days and 3 lab days.  
Nap condition: 90 min nap 
between 13:30 & 15:00 
every day. No nap 
condition: no napping & 
activity was encouraged. 
Estimated TNST (naps) for the week 40 – 83 min 
(58 ± 14 min). 
Nocturnal sleep in the nap condition (377 min) vs. 
no nap (397) p>0.15, 
No significant differences or trends in nocturnal 
sleep between nap & no – nap condition in the lab 
(375(57) & 366(31) p>0.25). 
Alertness based on the global vigor scale there 
appeared to be no significant difference between the 
nap and no nap conditions (66 vs. 65, p>0.25). 
Performance data indicated no evidence that the nap 
had any significant effect (p>0.25) 
Total 24 hr sleep duration 
> with nap sleep: Nap 
sleep + nocturnal sleep 
TNST: nap: 435 min, no 
nap: 397 min, p<0.025). 
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Appendix B 
ANCILLARY STUDY 
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B.1 THE HEALTH AGING AND BODY COMPOSITION – ANCILLARY STUDY: 
THE EFFECTS OF SLEEP ON DAYTIME FUNCTION 
This study was an ancillary study performed in conjunction with the Health Aging and Body 
Composition (Health ABC) eighth year clinic visit (2005). This study was designed, 
implemented, conducted, and analyzed as part of Ms. Goldman’s PhD thesis.  
B.2 RESEARCH AIMS AND HYPOTHESES 
Night time sleep problems and daytime sleepiness are common complaints in society, and 
especially in the older population. Both have been directly and indirectly correlated with reduced 
daytime performance and functioning, medical comorbidity and cognitive decline. We planned 
to use a combination sleep diary and wrist actigraphy to measure and quantify sleep duration, 
sleep fragmentation, and sleep quality in older adults. Our goal was to collect these data to 
address the following aims and hypotheses: 
Aim I: Determine if sleep duration, fragmentation, or quality as measured by sleep 
diaries and wrist actigraphy is related to fatigue as measured by: 
 
a) subjective daily report of fatigue and napping behavior, and  
b) objective measurement of performance as measured by the 400m walk test, grip 
strength, chair stands and standing balance test. 
 
Hypothesis I: Older adults who sleep <6 hours or >8 hours per night will report more 
fatigue and perform more poorly, than those who sleep between 6 to 8 hours. 
 
Hypothesis II: Older adults with more sleep fragmentation (nighttime movement) 
measured by wrist actigraphy will report more daytime fatigue and have lower daytime 
functioning compared to those with less sleep fragmentation (nighttime movement). 
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Hypothesis III: Older adults who report a better quality of sleep will report less fatigue, 
fewer naps, and perform better than those who report poorer quality sleep. 
 
Aim II: Determine if sleep duration, fragmentation, or quality are related to the 
prevalence of one or more falls in the past year by self report 
  
Hypothesis I: Older adults who sleep <6 hours or >8 hours per night will report fewer 
falls over the past year than older adults who sleep 7 to 8 hours. 
 
Hypothesis II: Older adults with more sleep fragmentation (nighttime movement) 
measured by wrist actigraphy will report a history of fewer falls in the past year than those older 
adults with lower sleep fragmentation (nighttime movement). 
 
Hypothesis III: Older adults who report a better quality of sleep will report fewer falls 
over the past year than older adults who report poorer sleep quality. 
 
Aim III: Determine if sleep duration, fragmentation, or quality are related to 
cognitive functions as measured by the Teng Mini Mental Status Exam  
 
Hypothesis I: Older adults who sleep <6 hours or >8 hours per night will have lower 
cognitive function than older adults who sleep 7 to 8 hours. 
 
Hypothesis II: Older adults with a more sleep fragmentation (nighttime movement) 
measured by wrist actigraphy will have lower cognitive function than older adults with lower 
sleep fragmentation (nighttime movement). 
 
Hypothesis III: Older adults who report better a better quality of sleep will perform better 
on cognitive function tests than older adults who report a poorer sleep quality. 
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B.2.1 Background and rationale 
Sleepiness, is generally felt to reflect a physiological need for sleep, impairing the ability of an 
individual to function effectively, subsequently reducing the quality of life 83, 109. Changes in 
sleep and sleep architecture that occur with aging can lead to sleep complaints in older adults 193. 
Fatigue, is often used interchangeably with sleepiness, and reflects a sensation of exhaustion 
during or after usual activities, or inadequate energy to begin activities 194. Both, daytime 
sleepiness and fatigue, are important factors in the health and quality of life in older individuals 
148, 195. While sleep needs remain similar throughout the lifespan, daytime sleepiness is more 
prevalent in the older and many factors make it difficult to obtain the requisite sleep 196, 197.  
Older individuals experience a wide range of sleep problems related to changes in 
medical, physical and behavioral factors. These include daytime sleepiness and fatigue, an 
inadequate amount of sleep (<6 hours), naps, obstructive sleep apnea, insomnia, restless legs 
syndrome, circadian rhythm disorders, and delayed sleep phase syndrome 16, 148, 196-199. Excessive 
daytime sleepiness has been reported to range from 10% to over 30% in the older 109, 200. 
Daytime sleepiness has been associated with multiple outcomes such as cardiovascular mortality 
23, 201, diabetes mellitus and impaired glucose tolerance 191, falls 202, cognitive and psychiatric 
disorders and impaired functional outcomes 200. While it has been suggested that daytime 
sleepiness is probably due to nocturnal disturbances such as frequent awakenings 109 the 
relationship between night time sleep patterns, daytime sleepiness, and health related outcomes 
are not fully understood.  
Individuals are thought to require between seven to nine hours of sleep nightly for 
optimum health and performance 196.  Older adults (55-84 year olds) average 7.0 hours of sleep 
on weeknights and 7.1 hours of sleep on weekends, however 13% sleep less than six hours and 
8% sleep more than nine hours and approximately 50% or higher, complain of some sleep 
difficulty 3, 4, 198. Evidence of adverse health effects associated with short or long sleep times, and 
daytime sleepiness is increasing. Individuals with four or more major medical conditions tend to 
sleep less than six hours, report poorer sleep quality and some type of sleep disorder compared to 
individuals who have three or less health problems 4.  
The Health ABC study population has well documented measurements of the study 
participants’ health and overall physical and mental function. The 8th year visit while measuring 
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medical, physical and behavioral components does not include any sleep related measures. As 
part of this ancillary study, we propose to add a sleep questionnaire, a self-administered sleep 
diary, and an actigraphy measurement of sleep performance to a subset of the Pittsburgh cohort 
to test the above hypotheses and evaluate the association of nighttime sleep, daytime napping, 
and fatigue on daytime function. 
B.3 METHODS AND PROCEDURES 
We asked 372 Health ABC participants from the Pittsburgh site at their 8th clinic visit (start date 
for the sleep study was 1/2005) to participate in this study. Participation in this study was 
entirely voluntary. Individuals were excluded if they had: end stage disease, lung disease or heart 
disease requiring oxygen, cancer under active treatment, cognitive impairment, or were unable to 
follow directions or complete a sleep diary. Participants were initially recruited based on the 
availability of a wrist actigraph (Mini-Mitter® AW-16) at the time of their visit. If a wrist 
actigraph was available, a staff member approached the participant and offered them the 
opportunity to participate in the ancillary study. In late-February 2005 enough watches had been 
obtained to offer a watch to all qualified participants. 
Participants who consented to participate in the sleep actigraphy study were asked a few 
additional questions about their daytime energy level, napping behavior, and sleep patterns. They 
were then asked to wear a small wrist actigraph on the non dominant arm designed to measure 
sleep duration and movement continuously for one week. They were also asked to record sleep 
related behaviors at bed time and during their wake time (e.g. sleep and wake times, naps, 
exercise) in a diary. The day after the week sleep study ended a driver for the study picked up the 
wrist actigraphy and diary from the participants’ home. In the middle of February the decision 
was made to ask the additional questionnaire to all Health ABC participants whether or not they 
chose to participate in the home portion of the study. The additional questions and instructions 
extended the clinic visit approximately 10 minutes. 
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B.3.1 Data analysis and statistical power 
B.3.2 Assumptions for statistical power calculations. 
We initially anticipated sampling to start the first week of Jan 2005 and to finish with the 
conclusion of the 8th year of the Health ABC study at the end of May 2005. Initial sample size 
was based on the availability of 15 wrist actiwatches worn by a participant for seven days plus a 
three to four day return and maintenance period. Assuming an average of nine wrist actigraphs in 
circulation at a time, four weeks in a month, and a 5 month sampling period, we projected being 
able to sample a minimum of 180 participants. In late February we obtained additional watches 
that enabled us to offer watches to all eligible participants. Based on our response to that time we 
projected a final sample size of 252. 
Initial sample size calculations were based on dividing the 180 participants into five 
groups based on data from the Health ABC baseline self report of hours slept each night 
(personal communication Dr. A. Newman): those who slept less than six hours; slept six hours; 
slept seven hours; slept 8 hours; and greater than eight hours, by percent (13.6%, 25.6%, 26.1%, 
28.8% and 6.1% respectively) based.  We performed t-tests on the equality of self reported 
energy (0 – 10 scale), Health ABC short performance battery (SPPB), and the Teng mini-mental 
exam (MMSE) using the calculated actual means and standard deviations from the Health ABC 
study at the 5th clinic visit (MMSE) and the 6th visit (Energy Scale, SPPB). We used the actual 
SD rate of change of 1.6477 for the energy scale, 1.8538 for the SPPB, and 0.1233 for the MME. 
Alpha was set at 0.05 and power = 0.80. To achieve adequate power, based on the previous data 
collected at the Health ABC baseline visit on hours slept per night, we double sampled the end 
populations (< 6 hours and > 8 hours) and assumed the remaining 3 categories to be equal. Mean 
detectable differences are presented below (Table 1). By using the actual mean (SD) from Health 
ABC we would be able to detect from 0.6084 SD when comparing 48 to 38 participants to 0.72 
SD between 48 - 22 participants. Table 2 presents revised calculations based on the revised 
sample size of 252 watches. 
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Table 1 Mean detectable difference based on 15 watches, estimated sample size (n= 180) 
 
Distribution based on Health ABC baseline self reported sleep data with sample size doubled at 
both ends: 
 < 6 hrs  6hrs  7 hrs  8 hrs  >8 hrs 
 
Baseline            13.6%          25.6%  26.1%  28.8%   6.1% 
n = 1                48            36   36    38    22 
 
Sample Sizes 
Compared 48 – 22 48 – 36 48 – 38 36 - 22 
Energy Scale (0-10) 
6.4739 (1.6477) 2 
1.1885 
(0.7213) 
1.0177 
(0.6176) 
1.0025 
(0.6084) 
1.2490 
(0.7580) 
SPPB (12 point scale) 
9.5633 (1.8538) 3 
1.3372 
(0.7213) 
1.1450 
(0.6177) 
1.1278 
(0.6084) 
1.4053 
(0.7581) 
MMSE 
1.007 (0.1233) 4 
0.0889 
(0.7210) 
0.0762 
(0.6180) 
0.0750 
(0.6083) 
0.0935 
(0.7583) 
 
1 Sample size reflects double sampling of the <6 hrs and >8 hrs groups 
2mean (SD) 
3  mean detectable difference between the 2 sample sizes. 
4 SD difference detectable. 
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Table 2 Mean detectable difference based on actual sample size (n=252) 
 
Distribution based on Health ABC self report data: 
  < 6 hrs  6hrs  7 hrs  8 hrs  >8 hrs    
        n =       51  60   67    53    21 
 
Sample Sizes Compared 51 - 21 60 - 21 60 - 67 
Energy Scale (0-10) 
6.1633(1.9435)(actual) 1.4116
2 1.3805 .9677 
SPPB (12 point scale) 
9.5633 (1.8538) 1 1.346 1.3168 .9231 
MMSE 
1.007 (0.1233) 1 .0896 .0876 .0614 
 
1 mean (SD)   
2  mean detectable difference between the 2 sample sizes. 
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B.3.3 Outcomes and covariates 
This ancillary study provided data for several analyses and analysis plans. The outcomes and 
potential confounders varied slightly for each analysis plan proposed. The following is a 
generalized list. 
Outcomes: 
- Wrist actigraphy: 
- Total nighttime sleep 
- Movement and fragmentation index 
- Wake after sleep onset 
- Total daytime sleep (naps) 
- Fatigue 
- Performance measures (400 meter walk speed, average grip strength, time to complete 5 
chair stands). 
Covariates: 
Available from the  Health ABC year 8 visit or through the ancillary study: 
- Age 
- Race 
- Sex 
- Body weight 
- BMI (kg/m2) 
- Self reported health status 
- Cardiopulmonary disease 
- Use of sleep medication 
- Cognitive Decline (3MS) 
- Depression (CES-D10) 
- Stress (Perceived stress scale) 
- Smoking 
- Alcohol use 
- Physical activity – minutes walking per week. 
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B.3.4 Statistical methods 
- Actigraphy data was collected using the Mini-Mitter Actiwatch that contains an 
electronic device that counts the number of arm movements per one-minute epoch, recording 
each minute’s total movement on a memory chip. Data collected was downloaded and analyzed 
with the Mini-Mitter Actiware sleep software v5®. 
- Descriptive statistics were performed on all major variables. 
- Sleep duration was calculated and participants categorized into quartiles, as well as into 
the 5 sleep classes defined above.  
- Movement & fragmentation percent was calculated using the Mini-Mitter software and 
evaluated and categorized into groups as appropriate. 
- Comparisons will be made between sleep groups with respect to potential covariates. 
- Correlations will be run between the main outcomes and major covariates with 
parametric and non-parametric methods as appropriate 
- Linear regression analyses will be performed to evaluate the relationships between the 
major outcomes and the independent variables.  Based on univariate significance multiple linear 
regressions will be performed as appropriate.  
B.3.5 Impact on the main study 
Our proposal had minimal impact on the main study and clinic site. Minimal burden was placed 
on the participant. The actual time of the clinic visit did not increase over 15 – 20 minutes for the 
participant. The participants were expected to wear the wrist-actigraph continuously for one 
week and to complete a sleep diary daily at bedtime and upon arising daily for a week 
(anticipated time about 10 minutes per day). The watches and diaries were picked up by the 
clinic drivers upon completion. 
   
 123
B.3.6 Costs. 
The ancillary study was funded through a Department of Epidemiology Small Grants Award to 
Ms. Goldman and supplemented with research and development funds from the study site. Ms. 
Goldman received a complimentary copy of the Actiware software from Mini-Mitter® for 
participating in testing the software upgrade. As a graduate student research assistant Ms. 
Goldman was funded by Dr. A. Newman. No additional costs were incurred by the main study or 
the coordinating center. Data was entered locally and will be merged with clean files upon 
completion of the ancillary study. 
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